Molecular pathology of age-related macular degeneration
Open accessAbstract
Age-related macular degeneration (AMD) is a leading cause of irreversible blindness in the world. Although the etiology and pathogenesis of AMD remain largely unclear, a complex interaction of genetic and environmental factors is thought to exist. AMD pathology is characterized by degeneration involving the retinal photoreceptors, retinal pigment epithelium, and Bruch’s membrane, as well as, in some cases, alterations in choroidal capillaries. Recent research on the genetic and molecular underpinnings of AMD brings to light several basic molecular pathways and pathophysiological processes that might mediate AMD risk, progression, and/or response to therapy. This review summarizes, in detail, the molecular pathological findings in both humans and animal models, including genetic variations in CFH, CX3CR1, and ARMS2/HtrA1, as well as the role of numerous molecules implicated in inflammation, apoptosis, cholesterol trafficking, angiogenesis, and oxidative stress.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 182 cited sources checked · 0 supported · 0 flagged
- Findingcitation
In 148 advanced AMD patients and 162 control subjects with infection, no relationship was found between the risk-conferring CFH variant and C. pneumoniae.
“We recently found no relationship between risk-conferring CFH variant and C. pneumoniae in 148 advanced AMD patients and 162 control subjects with the infection”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shen et al., 2008
Not checked in the free run.
- Findingcitation
There is a positive association between AMD and C. pneumoniae infection, with 20% versus 10% positive C. pneumoniae DNA detected in blood of AMD patients compared with controls.
“although there is a positive association between AMD and C. pneumoniae infection (20% vs. 10% positive C. pneumoniae DNA detected in the blood of AMD patients compared with the controls) (Shen et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shen et al., 2008
Not checked in the free run.
- Findingcitation
CX3CR1 transcript and protein in AMD maculae were undetectable or expressed at much lower levels than in normal eyes.
“This previous study showed that CX3CR1 transcript and protein in the AMD maculae were undetectable or expressed at much lower levels than their SNP-type counterparts in the normal eyes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chan et al., 2005
Not checked in the free run.
- Findingcitation
CX3CR1 expression is lower in the macula compared with the perimacular retina in AMD eyes bearing T280M.
“we found lowered CX3CR1 expression in the macula compared with the perimacular retina of AMD eyes bearing T280M.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chan et al., 2005
Not checked in the free run.
- Findingcitation
In normal eyes, macular cells from an individual bearing the at-risk T/M280 allele exhibited lower CX3CR1 transcript expression than an individual bearing the wild-type T280T allele.
“In normal eyes, macular cells from an individual bearing “at risk” allele T/M280 exhibited lower CX3CR1 transcript expression than an individual bearing “wild type or major” allele T280T.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chan et al., 2005
Not checked in the free run.
- Findingcitation
Similar levels of CX3CR1 expression were detected in macular and perimacular regions of normal subjects.
“In contrast, similar levels of CX3CR1 expression were detected in macular and perimacular regions of the normal subjects”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Chan et al., 2005
Not checked in the free run.
- Findingcitation
The frequency of the ARMS2 risk allele is higher in patients with advanced AMD than in those with early or intermediate AMD.
“Our data, including a population-based study (Wang et al., 2008), and data by Jakobsdottir and colleagues (Jakobsdottir et al., 2005) have both shown that the frequency of the ARMS2 risk allele is higher in patients with advanced AMD than in those with early or intermediate AMD.”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingcitation
In AMD eyes, there is a drastic decrease in normal mitochondria in photoreceptors and RPE cells compared to normal age-control eyes.
“Similar to findings by Feher and colleagues (Feher et al., 2006), we have also found a drastic decrease in normal mitochondria in the photoreceptors and RPE cells of the AMD eyes as compared to that of the normal age-control eyes (Fig. 5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Feher et al., 2006 source
Not checked in the free run.
- Findingcitation
ApoE112R (E4) is associated with a decreased risk of AMD development.
“We have also found the association between ApoE112R (E4) and a decreased risk of AMD development, and the underlying mechanisms might involve differential regulation of both CCL2 and VEGF by the ApoE isoforms (Bojanowski et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bojanowski et al., 2006 source
Not checked in the free run.
- Findingcitation
Compared with wild-type mice, Ccl2/Cx3cr1 double knockout mice have increased complement C3 and CD46.
“Compared to wild-type mice, Ccl2−/−/Cx3cr1−/− mice exhibited increased complement C3 and CD46.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ross et al., 2008 source
Not checked in the free run.
- Findingcitation
Ccl2/Cx3cr1 double knockout mice show ultrastructural AMD signs including lipofuscin granule accumulation and increased A2E accumulation on biochemical analysis.
“These mice also exhibited ultrastructural signs of AMD such as accumulation of lipofuscin granules, as well as increased the N-retinylidene–N-retinylethanolamine (A2E) accumulation on biochemical analysis (Chan et al., 2008; Tuo et al., 2007).”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingcitation
Serum from Ccl2/Cx3cr1 double knockout mice contains anti-retinal antibodies, as shown by incubation with normal retinal sections.
“Incubation of normal retinal sections with serum from Ccl2−/−/Cx3cr1−/− also demonstrated the presence of anti-retinal antibodies in the mouse model.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ross et al., 2008 source
Not checked in the free run.
- Findingcitation
The increase in C3d expression in Ccl2/Cx3cr1 double knockout mice is especially notable in Bruch's membrane, drusen-like lesions, photoreceptors, RPE, and choroidal capillaries.
“Analysis of C3d expression by immunoreactivity revealed that this increase was especially notable in Bruch’s membrane, drusen-like lesions, photoreceptors, RPE, and choroidal capillaries (Ross et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ross et al., 2008 source
Not checked in the free run.
- Findingcitation
Wild-type mice show minimal anti-retinal auto-antibody effect.
“In contrast, minimal anti-retinal auto-antibody effect was noted in wild-type mice (Ross et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ross et al., 2008 source
Not checked in the free run.
- Premisecitation
The most established risk factors for AMD are advanced age, cigarette smoking, diet, and race.
“studies have shown that the most established factors are advanced age, cigarette smoking, diet, and race (Coleman et al., 2008; Jager et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Coleman et al., 2008
Not checked in the free run.
- cites Jager et al., 2008 source
Not checked in the free run.
- Premisecitation
The majority of studies have found a statistically significant association between smoking and development of AMD.
“The majority of studies have found a statistically significant association between smoking and development of AMD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klein, 2007 source
Not checked in the free run.
- Premisecitation
The AREDS demonstrated that zinc-antioxidant supplements prevent or delay progression of early AMD to late AMD in high-risk patients.
“The AREDS demonstrated the efficacy of zinc-antioxidant supplements for preventing or delaying progression of early AMD to late AMD in patients who are at high risk (Bressler et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bressler et al., 2003 source
Not checked in the free run.
- Premisecitation
High dietary lutein and zeaxanthin intake reduced the risk of long-term incident AMD.
“A recent population-based cohort study in Australia (Tan et al., 2008) demonstrated that high dietary lutein and zeaxanthin intake reduced the risk of long-term incident AMD”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tan et al., 2008 source
Not checked in the free run.
- Premisecitation
Large, bilateral, and/or numerous drusen are significant risk factors for development of late stage AMD.
“The large drusen, bilateral drusen, and/or numerous drusen, are significant risk factors for development of late stage AMD.”
Quote in the paperNot a substantial claim - Interpretationcitation
The presence of inflammation-related molecules in drusen suggests possible involvement of the immune system in AMD pathogenesis.
“The presence of inflammation-related molecules in drusen suggests the possible involvement of the immune system in AMD pathogenesis (Hageman et al., 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hageman et al., 2001 source
Not checked in the free run.
- Premisecitation
High beta-carotene intake was associated with an increased risk of AMD.
“high beta-carotene intake was associated with an increased risk of AMD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tan et al., 2008 source
Not checked in the free run.
- Premisecitation
Patients with a family history of AMD are at increased risk.
“Several family studies have shown that patients with a family history of AMD are at increased risk (Seddon et al., 2007; Smith and Mitchell, 1998).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Seddon et al., 2007 source
Not checked in the free run.
- cites Smith and Mitchell, 1998
Not checked in the free run.
- Premisenone given
Subretinal extracellular deposits composed of glycoproteins and lipids accumulate in Bruch's membrane as drusen.
“Classically, subretinal, extracellular deposits composed of glycoproteins and lipids accumulate in Bruch’s membrane. These dumbbell shaped deposits are called drusen”
Quote in the paperNot a substantial claim - Premisecitation
The earliest pathological changes in AMD are the appearance of basal laminar deposits and basal linear deposits.
“The earliest pathological changes are the appearance of basal laminar deposits (BlamD) and basal linear deposits (BlinL) (Green and Enger, 1993).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Green and Enger, 1993 source
Not checked in the free run.
- Premisecitation
In a population-based study, the population-attributable risk for a positive family history of AMD was 0.34.
“The results showed that for AMD, the population-attributable risk (PAR) for a positive family history was 0.34.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Luo et al., 2008 source
Not checked in the free run.
- Premisenone given
The presence of large and many drusen in the macula signifies early AMD.
“However, the presence of large and many drusen in the macula signifies early AMD.”
Quote in the paperNot a substantial claim - Premisecitation
Drusen may be visible ophthalmoscopically when their diameter exceeds 25 μm.
“In the earliest stage, they may be visible ophthalmoscopically, when their diameter exceeds 25 µm (Sarks et al., 1999)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sarks et al., 1999 source
Not checked in the free run.
- Premisecitation
The most replicated linkage and association signals for AMD reside on chromosomes 1q25-31 and 10q26.
“Many linkage and association studies have indicated that the most replicated signals reside on chromosome 1q25–31 and 10q26 (Fisher et al., 2005; Jakobsdottir et al., 2005; Klein et al., 1998; Majewski et al., 2003).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen.
“Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen (Johnson et al., 2002).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Johnson et al., 2002 source
Not checked in the free run.
- Premisecitation
Complement components and complement regulatory proteins are present in drusen and nearby RPE of AMD patients.
“A number of studies have illustrated the presence of complement components and complement regulatory proteins in drusen and nearby RPE of AMD patients”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisenone given
The primary clinical characteristic of late stage dry AMD is RPE atrophy, usually known as geographic atrophy.
“The primary clinical characteristic of late stage ‘dry’ AMD is the appearance of RPE atrophy, usually known as geographic atrophy.”
Quote in the paperNot a substantial claim - Premisenone given
RAP occurs much less frequently than classical choroid-derived neovascular vessels.
“RAP, however, occurs much less frequently than the classical choroid-derived neovascular vessels.”
Quote in the paperNot a substantial claim - Premisecitation
Classical wet AMD most commonly involves new vessels sprouting from choroidal vessels, penetrating Bruch's membrane, and growing into the subretinal space.
“new vessels sprouting from the choroidal vessels, penetrating Bruch’s membrane and growing into the subretinal space are the classical descriptions of wet AMD (Green, 1999), which is most common”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Green, 1999
Not checked in the free run.
- Premisenone given
SNPs associated with inflammation, oxidative stress, angiogenesis, and other pathological processes have been linked to AMD.
“AMD is no exception, as SNPs associated with inflammation, oxidative stress, angiogenesis, and other pathological processes have been linked to AMD.”
Quote in the paperNot a substantial claim - Premisereasoning
Dysregulation of the complement cascade can result in complement overactivation-mediated damage to nearby healthy tissue.
“dysregulation of the cascade can result in complement overactivation-mediated damage to nearby healthy tissue.”
Quote in the paperNot a substantial claim - Premisecitation
Apolipoproteins B and E, immunoglobulins, factor X, amyloid P component, amyloid β, complement C5 and C5b-9 terminal complexes, fibrinogen, and vitronectin are present in all phenotypes of hard and soft drusen.
“Immunohistochemical analyses have shown various molecular constituents, such as apolipoproteins B and E, different immunoglobulins, factor X, amyloid P component, amyloid β, complement C5 and C5b-9 terminal complexes, fibrinogen, vitronectin, and others, to be present in all phenotypes of hard and soft drusen”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Hyperpigmentary changes associated with compensatory RPE cell proliferation are frequently observed at the periphery of hypopigmented areas.
“Hyperpigmentary changes associated with compensatory RPE cell proliferation are frequently observed at the periphery of these hypopigmented areas (de Jong, 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites de Jong, 2006 source
Not checked in the free run.
- Premisecitation
Complement activation generates pro-inflammatory responses including membrane-attack complexes, chemokine release, and increased capillary permeability.
“Activation of the complement system generates a variety of pro-inflammatory responses, including the production of membrane-attack complexes (MAC) which lead to cell lysis, release of chemokines to mediate recruitment of inflammatory cells, and enhancement of capillary permeability (Walport, 2001a, b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Walport, 2001a, b
Not checked in the free run.
- Premisenone given
Genetic studies have identified inflammation-associated SNPs that modulate AMD risk.
“These studies have been buttressed by genetic studies identifying inflammation-associated SNPs that modulate AMD risk.”
Quote in the paperSubstantial claim - Premisecitation
Elevated serum level of CRP is associated with AMD.
“elevated serum level of CRP has been shown to be associated with AMD (Mold et al., 1999; Seddon et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
CFH is a negative regulator of the complement system.
“CFH is a negative regulator of the complement system.”
Quote in the paperSubstantial claim - Premisecitation
Individuals homozygous for the risk-conferring Y402H CFH variant have higher levels of CRP in the choroid compared with individuals homozygous for the Y402 variant.
“Johnson and associates illustrated that individuals homozygous for the risk-conferring Y402H CFH variant have higher levels of CRP in the choroid compared to individuals homozygous for the “normal” Y402 variant.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Johnson et al., 2006 source
Not checked in the free run.
- Premisecitation
Animal models with complement knockdown, either genetic or pharmacological, exhibit decreased CNV after laser injury.
“several studies have demonstrated that animal models with complement knockdown, either genetically or with pharmacological agents such as anti-complement antibodies, exhibit decreased CNV after laser injury”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Patel and Chan, 2008
Not checked in the free run.
- Premisenone given
CFH is widely accepted as an important AMD susceptibility gene with variants and haplotypes associated with increased and reduced disease risk.
“CFH is now widely accepted as an important AMD susceptibility gene, harboring variants and haplotypes associated with increased and reduced disease risk.”
Quote in the paperSubstantial claim - Premisecitation
CFH is identified in normal RPE and choroid.
“CFH is identified in normal RPE and choroid (Klein et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klein et al., 2005 source
Not checked in the free run.
- Premisecitation
The risk-conferring Y402H CFH variant reduces binding affinity to C-reactive protein compared with the Y402Y variant.
“The risk-conferring Y402H CFH variant (genotype CC) has also been reported to reduce the binding affinity to C-reactive protein (CRP), a pro-inflammatory molecule, as compared with the Y402Y variant (genotype TT).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
The Y402H variant of complement factor H is a major AMD-associated SNP.
“A major AMD-associated SNP is the Y402H (tyrosine to histidine substitution at amino acid 402) variant of complement factor H (CFH) (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
C. pneumoniae has been found in AMD neovascular membranes.
“Moreover, C. pneumoniae has been found in AMD neovascular membranes (Kalayoglu et al., 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kalayoglu et al., 2005 source
Not checked in the free run.
- Premisecitation
The presence of the risk-conferring CFH variant and high C. pneumoniae antibody titer significantly increases AMD risk beyond the risk associated with either factor alone.
“a recent study demonstrating that the presence of the risk-conferring CFH variant and high C. pneumoniae antibody titer significantly increases AMD risk, well beyond the risk associated with possessing either risk factor alone (Baird et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Baird et al., 2008 source
Not checked in the free run.
- Interpretationcitation
These results support the notion that the association between CFH polymorphisms and AMD may involve CRP.
“These results support the notion that the association between CFH polymorphisms and AMD may involve CRP.”
Quote in the paperSubstantial claim - Premisenone given
Three CFH SNPs at rs1061147, rs1061170, and rs380390 are in complete linkage disequilibrium.
“The three SNPs at rs1061147, rs1061170, and rs380390 are in complete linkage disequilibrium (LD).”
Quote in the paperNot a substantial claim - Premisecitation
In addition to Y402H, five other CFH variants have been reported in AMD association studies.
“In addition to the CFH Y402H (dbSNP ID: rs1061170) SNP, 5 other CFH variants (rs3753394, rs800292, rs1061147, rs1061170, rs380390, and rs1329428) have been reported in AMD association studies.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The particular CFH SNPs associated with AMD depend upon the study and the study population.
“The particular SNPs associated with AMD, however, depend upon the study and the study population.”
Quote in the paperNot a substantial claim - Premisenone given
Among these CFH SNPs, rs1061170 (Y402H) is the only SNP that leads to a non-synonymous amino acid change.
“Among them, the rs1061170 (Y402H) was the only SNP that leads to a non-synonymous amino acid change.”
Quote in the paperNot a substantial claim - Premisecitation
There is no significant difference between YY and HH CFH phenotypes in the amount of CFH protein in the RPE-choroid complex.
“In contrast, there is no significant difference between the two phenotypes (YY and HH) in the amount of CFH protein in the RPE-choroid complex (Johnson et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Johnson et al., 2006 source
Not checked in the free run.
- Premisenone given
C. pneumoniae is a potent activator of the alternative complement system.
“C. pneumoniae is a potent activator of the alternative complement system”
Quote in the paperSubstantial claim - Interpretationreasoning
Studies to date demonstrate an association between CFH and AMD.
“Thus, studies to date demonstrate an association between CFH and AMD.”
Quote in the paperSubstantial claim - Premisecitation
In Chinese and Japanese populations, only CFH SNPs at rs1329428, rs800292 (I62V), and rs3753394, but not rs1061170 (Y402H), are associated with risk of exudative AMD.
“In the Chinese and Japanese populations, only three of these CFH SNPs–at rs1329428, rs800292 (I62V), and rs3753394, but not at rs1061170 (Y402H)–were associated with risk of exudative AMD (Chen et al., 2006; Okamoto et al., 2006).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Chen et al., 2006
Not checked in the free run.
- cites Okamoto et al., 2006
Not checked in the free run.
- Premisecitation
These CFH SNPs have been reported to be major genetic factors for developing AMD in Caucasians.
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationcitation
Zinc plus antioxidative treatment seems to have less impact on those with the high-risk CFH variant.
“These results suggest that the zinc plus antioxidative treatment seems to have less impact on those with the high-risk CFH variant.”
Quote in the paperSubstantial claim - Premisecitation
The SNP rs2511989 in SERPING1, encoding complement component 1 inhibitor, occurs less frequently in AMD cases than in control subjects.
“the SNP variant rs2511989 located in the SERPING1 gene encoding the complement component 1 (C1) inhibitor was recently reported to occur less frequently in AMD cases than in control subjects (Ennis et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ennis et al., 2008
Not checked in the free run.
- Interpretationown data
CFH may not be directly involved in the pathogenesis of C. pneumoniae infection-mediated AMD.
“Therefore, CFH may not be directly involved in the pathogenesis of C. pneumoniae infection-mediated AMD.”
Quote in the paperSubstantial claim - Premisecitation
The C3F allotype has been reported to be strongly associated with AMD in a study from English and Scottish populations.
“the fast migrating allotype (C3F), has been reported to be strongly associated with AMD in a study from English and Scottish populations (Yates et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yates et al., 2007 source
Not checked in the free run.
- Premisecitation
In a French study, homozygosity for the CX3CR1 T280M allele was associated with AMD.
“In a French study, homozygosity for the CX3CR1 T280M allele was also reported to be associated with AMD (Combadiere et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
- Premisecitation
The R32Q BF variant leads to impairment in the complement activating function of BF.
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gold et al., 2006 source
Not checked in the free run.
- Premisecitation
C7 rs2876849 is protective for AMD development in Caucasians.
“One study reported that C7 (rs2876849) is protective for AMD development in Caucasians (Dinu et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Dinu et al., 2007 source
Not checked in the free run.
- Premisecitation
A similar interaction was observed for zinc versus no zinc: zinc intake had a more protective effect in patients with non-risk alleles than in patients with risk alleles.
“In addition, a similar interaction was observed in the groups taking zinc versus those taking no zinc: zinc intake had a more dramatic protective effect in patients with non-risk alleles, compared with patients with risk alleles.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Klein et al., 2008a
Not checked in the free run.
- Premisereasoning
Membranoproliferative glomerulonephritis type II shares similarities with AMD, namely a role for uncontrolled alternative complement activation and accumulation of complement-containing extracellular deposits.
“This glomerulonephritis shares some similarities with AMD—namely, a role for uncontrolled alternative complement activation as well as the accumulation of complement-containing extracellular deposits.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Decreased complement activation by BF might protect against AMD risk.
“Thus, much like impaired CFH-mediated complement inhibition confers AMD risk, decreased complement activation by BF might serve to protect against AMD risk.”
Quote in the paperSubstantial claim - Premisecitation
In 86 wet AMD patients, only 10.5% of those with the risk-conferring Y402H/Y402H phenotype demonstrated improved vision with intravitreal bevacizumab, compared with 53.7% of those with Y402Y/Y402Y and Y402Y/Y402H CFH variants.
“The results show that only 10.5% of patients with the risk-conferring Y402H/Y402H phenotype demonstrated improved vision with treatment, compared with 53.7% of patients with the Y402Y/Y402Y and Y402Y/Y402H CFH variants (P = 0.004) (Brantley et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brantley et al., 2008
Not checked in the free run.
- Premisecitation
Subsequent studies demonstrated no significant association of the D299G TLR4 SNP with AMD risk.
“Subsequent studies, for example by Despriet and Edwards, however, demonstrated no significant association of the D299G TLR4 SNP with AMD risk (Despriet et al., 2008; Edwards et al., 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
SNPs in IL1β C511T, IL6 C174G, and IL10 G1082A showed no significant association with AMD.
“SNPs in other pro-inflammatory chemokines including interleukin-1β (IL1β) C511T, interleukin-6 (IL6) C174G and the anti-inflammatory cytokine IL10 G1082A were analyzed and showed no significant association with AMD (Goverdhan et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Goverdhan et al., 2008 source
Not checked in the free run.
- Premisecitation
CX3CR1-positive microglial cells accumulated subretinally in affected areas of the macula in AMD cases.
“Their immunohistochemical analysis of AMD cases suggest that CX3CR1-positive microglial cells accumulated subretinally in affected areas of the macula”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
- Premisecitation
Taiwan Chinese carriers of the IL8 C781T variant, independent of the CFH Y402H variant, have increased risk of developing wet AMD.
“Taiwan Chinese carriers of the IL8 C781T variant, independent to the CFH Y402H variant, have also been shown to be at increased risk of developing wet AMD (Tsai et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tsai et al., 2008 source
Not checked in the free run.
- Premisecitation
The IL8 AA genotype has been shown to induce angiogenesis in rat cornea.
“The AA genotype has also been shown to induce angiogenesis in rat cornea (Koch et al., 1992).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Koch et al., 1992 source
Not checked in the free run.
- Interpretationcitation
CX3CR1-mediated decreases in inflammatory cell chemokinesis might contribute to age-related changes in the macula.
“which suggested that CX3CR1-mediated decreases in inflammatory cell chemokinesis might contribute to age-related changes in the macula (Chan et al., 2005; Tuo et al., 2004)”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Chan et al., 2005
Not checked in the free run.
- cites Tuo et al., 2004 source
Not checked in the free run.
- Premisecitation
Heterozygosity at ARMS2/LOC387715 (A69A/A69S) is associated with an odds ratio of 1.69-3.0 for advanced AMD after controlling for demographic and behavioral risk factors.
“Heterozygozity at the ARMS2/LOC387715 (A69A/A69S) is associated with odds ratio (OR) of 1.69–3.0 for advanced AMD, while homozygosity for the risk conferring allele (A69S/A69S) results in an OR of 2.20–12.1, after controlling for demographic and behavioral risk factors (Ross et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ross et al., 2007 source
Not checked in the free run.
- Premisecitation
Chromosome 10q26 may contain a common AMD gene.
“A genome-wide scan and genetic linkage analysis of 70 families with AMD suggests that chromosome 10q26 may contain a common AMD gene (Majewski et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Majewski et al., 2003 source
Not checked in the free run.
- Premisecitation
The risk-conferring ARMS2/LOC387715 SNP A69S is associated with AMD.
“The risk-conferring ARMS2/LOC387715 SNP, A69S, is associated with AMD.”
Quote in the paperSubstantial claim - Premisecitation
Homozygosity for the risk-conferring allele (A69S/A69S) results in an odds ratio of 2.20-12.1 for advanced AMD after controlling for demographic and behavioral risk factors.
“Heterozygozity at the ARMS2/LOC387715 (A69A/A69S) is associated with odds ratio (OR) of 1.69–3.0 for advanced AMD, while homozygosity for the risk conferring allele (A69S/A69S) results in an OR of 2.20–12.1, after controlling for demographic and behavioral risk factors (Ross et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ross et al., 2007 source
Not checked in the free run.
- Premisecitation
The association of the ARMS2 gene with AMD, especially advanced AMD, has been replicated in many independent studies.
“The association of ARMS2 gene with AMD, especially advanced AMD, susceptibility has now been replicated in numbers of independent studies (Conley et al., 2006; Rivera et al., 2005; Ross et al., 2007; Schmidt et al., 2006; Seddon et al., 2007; Kanda et al., 2007).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Patients with both the risk-conferring ARMS2 variant and elevated serum levels of inflammatory markers (CRP, IL-6, sICAM-1) have stronger AMD risk.
“Interestingly, an even stronger effects on AMD risk has been noted in patients with both the risk-conferring ARMS2 variant and elevated serum levels of several inflammatory markers including CRP, IL-6, soluble intercellular adhesion molecule 1 (sICAM-1) (Wang et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wang et al., 2008 source
Not checked in the free run.
- Premisecitation
Individuals homozygous for the risk allele (AA) express higher levels of HtrA1 in circulating lymphocytes in vivo compared with individuals homozygous for the non-risk variant (GG).
“In the same study, individuals homozygous for the risk allele (genotype AA) expressed higher levels of HtrA1 in their circulating lymphocytes in vivo, compared with individuals homozygous for the non-risk variant (genotype GG).”
Quote in the paperNot a substantial claim - Premisereasoning
ARMS2 expression is absent or at least sufficiently low to be experimentally undetectable in homozygous carriers of the deletion-insertion variant.
“As a consequence, expression of ARMS2 in homozygous carriers of the deletion-insertion variant is absent, or at least sufficiently low to be experimentally undetectable.”
Quote in the paperSubstantial claim - Interpretationcitation
Oxidative stress plays an important role in AMD.
“First, studies have shown that human donor AMD eyes contain higher levels of protein adducts resulting from the oxidative modification of carbohydrates and lipids (Crabb et al., 2002; Howes et al., 2004) and higher levels of antioxidant enzymes (Decanini et al., 2007; Frank et al., 1999) compared with non-AMD eyes, which indicate that oxidative stress plays an important role in AMD.”
Quote in the paperSubstantial claim - Premisecitation
The risk allele A of rs11200638 enhances HtrA1 transcription in vitro in RPE cell lines.
“As rs11200638 is located within a CpG island of the proximal promoter, 512 bp upstream of the HtrA1 transcription start site, the risk allele “A” of HtrA1 SNP was shown to enhance HtrA1 transcription in vitro in RPE cell lines (Dewan et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Dewan et al., 2006 source
Not checked in the free run.
- Premisecitation
ARMS2 is localized to the ellipsoid region of photoreceptors in the retina, where most mitochondria are located.
“Kanda et al. reported that ARMS2 is localized to the ellipsoid region of the photoreceptors in retina, where most of the mitochondria are located (Kanda et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kanda et al., 2007 source
Not checked in the free run.
- Premisecitation
The deletion-insertion polymorphism *372_815delins54 in the 3′-UTR of ARMS2 is significantly associated with AMD.
“More recently, Fritsche et al. showed that a deletion-insertion polymorphism (*372_815delins54), which resides within the 3′-UTR of the ARMS2 gene, also associates very significantly with AMD (Fritsche et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fritsche et al., 2008 source
Not checked in the free run.
- Interpretationcitation
The mechanisms underlying the association between ApoE112R and decreased AMD risk might involve differential regulation of CCL2 and VEGF by ApoE isoforms.
“We have also found the association between ApoE112R (E4) and a decreased risk of AMD development, and the underlying mechanisms might involve differential regulation of both CCL2 and VEGF by the ApoE isoforms (Bojanowski et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bojanowski et al., 2006 source
Not checked in the free run.
- Premisecitation
Elevated expression of HtrA1 mRNA and/or protein in drusen and CNV components has been reported in AMD patients carrying the AA risk genotype.
“Elevated expression of HtrA1 mRNA and/or protein in the drusen and CNV components in AMD patients carrying the AA risk genotype has been reported in several studies (Cameron et al., 2007; Chan et al., 2007; Tuo et al., 2008; Yang et al., 2006) (Fig. 6).”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
ApoE may play a role in AMD pathology via retinal lipid trafficking.
“These findings suggest a possible role for ApoE in AMD pathology via retinal lipid trafficking (Ishida et al., 2004).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ishida et al., 2004 source
Not checked in the free run.
- Premisecitation
ApoE is present in drusen in AMD patients.
“In AMD patients, the presence of ApoE has been illustrated in drusen (Shanmugaratnam et al., 1997).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shanmugaratnam et al., 1997 source
Not checked in the free run.
- Premisecitation
VEGF plays a critical role in the pathogenesis of neovascular AMD.
“VEGF plays a critical role in the pathogenesis of neovascular AMD, and recently, therapies targeting VEGF have shown promising results of significant improvement of central vision and reduction of CNV (Wylegala and Teper, 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wylegala and Teper, 2007
Not checked in the free run.
- Premisenone given
SNP analyses have confirmed the association of ARMS2 and HtrA1 with AMD.
“Although the exact biological roles of both the ARMS2 and HtrA1 genes in humans are unclear, SNP analyses have confirmed their association with AMD.”
Quote in the paperSubstantial claim - Premisecitation
A large, population-based, cross-sectional study (n = 10,139) from the Atherosclerosis Risk in Communities Study found no association between AMD and any of the ApoE alleles.
“However, a large, population-based, cross-sectional study (n = 10,139) using participants from the Atherosclerosis Risk in Communities Study found no association between AMD and any of the ApoE alleles in Australia (Kaur et al., 2006; Schmidt et al., 2005; Schultz et al., 2003; Wong et al., 2006).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisenone given
There is ample evidence that inflammation plays an important role in both dry and wet AMD.
“There is ample evidence that inflammation plays an important role in both dry and wet AMD.”
Quote in the paperSubstantial claim - Interpretationreasoning
DNA repair mechanisms may play a role in AMD pathogenesis.
“These data suggest that DNA repair mechanisms may play a role in AMD pathogenesis.”
Quote in the paperSubstantial claim - Premisecitation
Macrophages are present at neovascular membranes in wet AMD.
“Several groups have demonstrated the presence of macrophages at neovascular membranes in wet AMD (Dastgheib and Green, 1994; Grossniklaus et al., 2002; Penfold et al., 2001).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Dastgheib and Green, 1994
Not checked in the free run.
- cites Grossniklaus et al., 2002
Not checked in the free run.
- cites Penfold et al., 2001 source
Not checked in the free run.
- Premisecitation
Variants in one allele of the ABCA4 gene were identified in 16% of AMD patients.
“They identified variants in one allele of the gene in 16% of the AMD patients (Allikmets, 1997; Allikmets et al., 1997).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Allikmets, 1997
Not checked in the free run.
- cites Allikmets et al., 1997
Not checked in the free run.
- Premisecitation
Multiple subsequent studies showed little or no relation of ABCA4 mutations with AMD.
“Moreover, multiple subsequent studies showed little or no relation of ABCA4 mutations with AMD (Bojanowski et al., 2005; De La Paz et al., 1999; Souied et al., 2000; Stone et al., 1998).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Bojanowski et al., 2005
Not checked in the free run.
- cites De La Paz et al., 1999 source
Not checked in the free run.
- cites Souied et al., 2000
Not checked in the free run.
- Premisecitation
Macrophages in CNV lesions express proangiogenic factors such as VEGF and tissue factor.
“Moreover, macrophages in CNV lesions have been shown to express proangiogenic factors such as VEGF and tissue factor (Csaky et al., 2004; Grossniklaus et al., 2002).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Csaky et al., 2004 source
Not checked in the free run.
- cites Grossniklaus et al., 2002
Not checked in the free run.
- Premisecitation
Inflammatory cells, particularly macrophages, have been histologically demonstrated near AMD lesions, including in areas of Bruch membrane breakdown, RPE atrophy, and choroidal neovascularization.
“While AMD is not a classic inflammatory disease like uveitis; inflammatory cells, in particular the macrophages, have been histologically demonstrated near AMD lesions, including in areas of Bruch membrane breakdown, RPE atrophy, and choroidal neovascularization (Coleman et al., 2008; Dastgheib and Green, 1994; Green, 1999; Grossniklaus et al., 2002; Lopez et al., 1993; Penfold et al., 2001).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Coleman et al., 2008
Not checked in the free run.
- cites Dastgheib and Green, 1994
Not checked in the free run.
- cites Green, 1999
Not checked in the free run.
- Premisecitation
A disease odds ratio of 23 is conferred by homozygosity for risk alleles at both ERCC6 and CFH compared with homozygosity for non-risk alleles.
“A disease OR of 23 was conferred by homozygosity for risk alleles at both ERCC6 and CFH compared with homozygosity for non-risk alleles.”
Quote in the paperSubstantial claim - Premisecitation
There is little evidence to support an association of the VEGF-A gene with AMD.
“However, Richardson et al. (2007) provided a thorough tag-SNP based examination and found little evidence to support an association of the VEGF-A gene with AMD.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Richardson et al., 2007
Not checked in the free run.
- Premisecitation
CX3CR1 SNPs T280M and V249I have been associated with increased risk of AMD in some reports.
“As described above, the CX3CR1 chemokine receptor found on microglia has been shown to harbor SNPs (T280M and V249I) that have been associated with increased risk of AMD in some reports (Chan et al., 2005; Tuo et al., 2004).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Chan et al., 2005
Not checked in the free run.
- cites Tuo et al., 2004 source
Not checked in the free run.
- Interpretationreasoning
CX3CR1 SNPs might lead to impaired microglial migration or egress from the retina, resulting in accumulation of microglia.
“Since microglia are already present in the retina since embryological development and do not chemotactically enter the retina, these SNPs might lead to impaired microglial migration or egress from the retina, resulting in accumulation of microglia.”
Quote in the paperSubstantial claim - Premisecitation
By 16-18 months of age, Ccl2−/− and Ccr2−/− mice develop geographic RPE atrophy and choroidal neovascularization.
“Eventually, by 16–18 months of age, Ccl2−/− and Ccr2−/− mice also develop geographic RPE atrophy and choroidal neovascularization.”
Quote in the paperNot a substantial claim - Interpretationcitation
Microglia contribute to drusen-like deposits.
“The notion that microglia contribute to drusen-like deposits is further strengthened by another study demonstrating that increasing fundus autofluorescence seen in aging wild-type mice consists of perivascular and subretinal microglia, which might also contain lipofuscin granules (Xu et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xu et al., 2008
Not checked in the free run.
- Premisenone given
The role of macrophages in CNV is controversial as to whether they serve an adaptive role to combat CNV or a causative role in inducing CNV.
“While the presence of macrophages at CNV lesions is largely recognized, the role of these macrophages presents some controversy as to whether these macrophages serve an adaptive role to combat CNV or a causative role in inducing CNV.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The Ccl2 and Ccr2 knockout mouse models of AMD point to macrophages having a protective function in AMD by clearing deposits.
“In short, the Ccl2−/− and Ccr2−/− murine models of AMD suggest a protective role for macrophages in AMD pathogenesis—clearance of deposits.”
Quote in the paperSubstantial claim - Premisecitation
The CX3CR1 SNP is associated with impaired microglial chemotaxis.
“The CX3CR1 SNP is associated with impaired microglial chemotaxis (Combadiere et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
- Premisecitation
Many activated microglia are present in macular lesions of AMD retinas.
“Indeed, histological analysis of AMD retinas has depicted the presence of many activated microglia in the macular lesions (Gupta et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gupta et al., 2003 source
Not checked in the free run.
- Premisereasoning
Impaired macrophage recruitment in Ccl2 and Ccr2 deficient mice is associated with accumulation of C5, IgG, and other drusen constituents within the retina.
“As expected, impaired macrophage recruitment in Ccl2 and Ccr2 deficient mice was associated with an accumulation of C5, IgG, and other drusen constituents within the retina.”
Quote in the paperSubstantial claim - Premisenone given
The Ccl2 and Ccr2 knockout mouse model of AMD has CNV as a pathological feature.
“The pathological features of this model include CNV.”
Quote in the paperSubstantial claim - Premisecitation
Ccl2−/− and Ccr2−/− mice exhibit AMD-like drusen visible fundoscopically by 9 months of age.
“Ambati and colleagues demonstrated that the Ccl2- and Ccr2 knockout mice (Ccl2−/− and Ccr2−/−) exhibit AMD-like drusen visible fundoscopically by 9 months of age.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Ambati et al., 2003 source
Not checked in the free run.
- Premisecitation
Macrophages play a protective role in CNV.
“On the other hand, Apte and colleagues, using a model of interleukin-10 (IL-10) deficient mice, found that macrophages play a protective role in CNV (Apte et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Apte et al., 2006 source
Not checked in the free run.
- Interpretationreasoning
Murine retinal degenerative diseases can provide relevant information that helps understanding of human AMD.
“However, murine retinal degenerative diseases can still provide relevant information that will help our understanding of human AMD.”
Quote in the paperSubstantial claim - Premisecitation
In Ccl2 knockout mice, reduced macrophage influx after laser injury is associated with less laser-induced CNV.
“Tsutsumi et al. demonstrating that decreased macrophage influx after laser injury to Ccl2−/− mice is associated with reduced laser-induced CNV (Tsutsumi et al., 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tsutsumi et al., 2003 source
Not checked in the free run.
- Interpretationcitation
Accumulated microglia might cause direct damage to photoreceptors.
“These accrued microglia might cause direct damage to the photoreceptors.”
Quote in the paperSubstantial claim - Premisecitation
Activated microglia can directly injure photoreceptor cells in vitro.
“as mentioned above, in vitro studies have demonstrated that activated microglia are capable of directly injuring photoreceptor cells (Roque et al., 1999).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Roque et al., 1999 source
Not checked in the free run.
- Interpretationreasoning
Microglial accumulation may play a role in the inflammatory cascade associated with AMD.
“Taken together, these studies suggest a potential role for microglia accumulation in the inflammatory cascade associated with AMD.”
Quote in the paperSubstantial claim - Premisecitation
CX3CR1 positive cells in drusen and near CNV membranes are microglial cells in human AMD eyes.
“CX3CR1 positive cells in drusen and near CNV membranes are microglial cells in human AMD eyes (Combadiere et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
- Interpretationreasoning
These findings strengthen the argument for a critical inflammatory component to AMD pathogenesis.
“They also strengthen the argument for a critical inflammatory component to AMD pathogenesis.”
Quote in the paperSubstantial claim - Premisecitation
At age 2 years, cfh knockout mice have significantly reduced visual acuity and rod response amplitudes on electroretinography compared with age-matched controls.
“At age 2 years, cfh−/− mice exhibited significantly reduced visual acuity and rod response amplitudes on electroretinography as compared with age-matched control mice (Coffey et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Coffey et al., 2007 source
Not checked in the free run.
- Interpretationreasoning
The ApoE4 high fat cholesterol rich model is an improvement over the prior ApoE-Leiden plus high fat diet model, which showed only basal laminar deposits in Bruch's membrane.
“This model is in fact an improvement upon the prior ApoE-Leiden plus high fat diet model, which demonstrated only basal laminar deposits in Bruch’s membrane.”
Quote in the paperSubstantial claim - Premisecitation
Both ApoE2 and ApoE4 transgenic mice develop extensive retinal, RPE, and choroidal degeneration after a high fat cholesterol rich diet.
“In contrast, both ApoE2 and ApoE4 transgenic mice developed extensive retinal, RPE, and choroidal degeneration after a high fat cholesterol rich (HF-CR) diet.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Malek et al., 2005 source
Not checked in the free run.
- Interpretationcitation
Recent studies in Abcr knockout mice highlight potential mechanisms underlying maculopathy in patients with putative risk-conferring ABCA4 polymorphisms and perhaps AMD in general.
“recent studies in an abcr (abca4) knockout mouse (Abcr−/−) highlight potential mechanisms underlying maculopathy in patients with putative risk-conferring ABCA4 polymorphisms and perhaps even AMD in general.”
Quote in the paperSubstantial claim - Interpretationreasoning
The findings from the ApoE mouse study are somewhat contrary to several prior epidemiological studies that showed a protective, rather than risk-conferring, role for the ApoE4 variant.
“The findings from this study are somewhat contrary to several prior epidemiological studies that demonstrated a protective, rather than risk-conferring, role for the ApoE4 variant.”
Quote in the paperSubstantial claim - Premisereasoning
Polymorphisms in the ABCA4 gene might contribute to AMD pathogenesis.
“As discussed above, polymorphisms in the ABCA4 gene might contribute to AMD pathogenesis”
Quote in the paperSubstantial claim - Premisecitation
In addition to photoreceptor degeneration and lipofuscin accumulation, the Abcr knockout model demonstrates decreased recovery of rod cell sensitivity after light exposure.
“In addition to photoreceptor degeneration and lipofuscin accumulation, this model also demonstrates decreased recovery of rod cell sensitivity after light exposure (Midena et al., 1997; Weng et al., 1999).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Midena et al., 1997
Not checked in the free run.
- cites Weng et al., 1999 source
Not checked in the free run.
- Premisecitation
The lipid accumulation effect is more pronounced in ApoE2 transgenic mice fed a high fat diet.
“This effect was even more pronounced in ApoE2 transgenic mice fed with a high fat diet.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee et al., 2007
Not checked in the free run.
- Premisecitation
In ApoE transgenic mice, ApoE status alone minimally affects retinal changes during aging, regardless of diet.
“They found that diet withstanding, ApoE status alone affected retinal changes during aging only minimally.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Malek et al., 2005 source
Not checked in the free run.
- Premisecitation
In contrast to wild-type eyes, mice expressing ApoE2 exhibit signs of lipid accumulation in the RPE and Bruch's membrane.
“The role of cholesterol metabolism in AMD has been further supported by recent studies demonstrating that, in contrast to wild-type eyes, mice expressing ApoE2 exhibited signs of lipid accumulation in the RPE and Bruch’s membrane (Lee et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lee et al., 2007
Not checked in the free run.
- Premisenone given
The retina and macula are highly susceptible to oxidative stress due to elevated oxygen tension, high metabolic activity, photoradiation exposure, photosensitizers, and photoreceptor phagocytosis.
“The retina in general, and macula in particular are highly susceptible to oxidative stress given the elevated oxygen tension, high metabolic activity, exposure to photoradiation, presence of photosensitizers, and oxidizing processes of photoreceptor phagocytosis.”
Quote in the paperSubstantial claim - Interpretationreasoning
Recent findings of genetic links between complement system members, including C1, C2, C3, C7, BF, and especially CFH, provide a compelling argument for complement over-activation in AMD pathogenesis.
“Recent findings demonstrating a genetic link between the complement system members including C1, C2, C3, C7, BF, and especially, CFH provide a compelling argument for complement over-activation in AMD pathogenesis.”
Quote in the paperSubstantial claim - Interpretationreasoning
The association of ApoE alleles with AMD and recent ApoE-based animal models suggest a potential role for aberrant cholesterol and lipid trafficking and metabolism in AMD pathogenesis.
“The association of ApoE alleles with AMD, as well as recent ApoE-based animal models of AMD, suggest a potential role for aberrant cholesterol and lipid trafficking and metabolism in AMD pathogenesis.”
Quote in the paperSubstantial claim - Interpretationreasoning
AMD appears to be a highly multifactorial disease likely caused by individual-specific combinations of etiological and risk factors that affect the disease and its response to treatments.
“Moreover, AMD appears to be a highly multifactorial disease likely caused by individual-specific combinations of etiological and risk factors that affect not only the disease itself but also its response to various treatment modalities.”
Quote in the paperSubstantial claim - Premisecitation
In a recent study of 23,720 transcripts from blood (n=1002) or adipose tissue (n=673), over 50% of adipose sample findings correlated with clinical trial findings related to obesity, compared to less than 10% for blood samples.
“For example, in a recent study on the expression of 23,720 transcripts from trials on blood samples (n = 1002) or adipose tissue (n = 673), findings from over 50% of trials in adipose samples correlated to those from clinical trials related to obesity, compared to less than 10% in trials on blood samples (Emilsson et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Emilsson et al., 2008 source
Not checked in the free run.
- Interpretationnone given
Compared to complement, the precise role of macrophages and microglia in AMD pathogenesis-whether protective, harmful, or both-is less clear.
“Compared to the scenario with complement, the precise role of macrophages and microglia in AMD pathogenesis—i.e. deciphering whether they are protective, harmful, or both—is less clear.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Recent studies on the molecular pathology of AMD suggest important roles for oxidative stress, inflammation, lipid metabolism, and angiogenesis.
“Recent studies on the molecular pathology of AMD suggest important roles for oxidative stress, inflammation, lipid metabolism, and angiogenesis.”
Quote in the paperSubstantial claim - Premisecitation
AMD patients with a risk-conferring CFH SNP showed less response to antioxidant and zinc therapy compared to those without the SNP.
“For example, AMD patients with risk-conferring CFH SNP showed less response to antioxidant and zinc therapy as compared to those without the SNP (Klein et al., 2008a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klein et al., 2008a
Not checked in the free run.
- May combine two claims. 58
- Classified as probably not a substantial claim. 17
May combine two claims.
FindingcitationThe V249I and T280M CX3CR1 SNPs confer increased risk of AMD, with odds ratios of 1.86 (1.04-3.31) for V249I and 1.94 (1.02-3.69) for T280M.
“We have reported that the V249I (valine to isoleucine at amino acid 249) and T280M (threonine to methionine at amino acid 280) CX3CR1 SNPs confer increased risk of AMD (Tuo et al., 2004). The OR (CI) of these two SNPs were 1.86 (1.04–3.31) for V249I and 1.94 (1.02–3.69) for T280M.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tuo et al., 2004 source
Not checked in the free run.
May combine two claims.
Findingcitationrs11200638 is associated with dry AMD with an odds ratio of 2.17 and wet AMD with an odds ratio of 2.97.
“By examining four cohort studies, we have also confirmed this association with ORs of 2.17 and 2.97 for dry and wet AMD, respectively (Tuo et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tuo et al., 2008 source
Not checked in the free run.
May combine two claims.
FindingcitationMacrophage and microglial accumulation is increased relative to wild-type in Ccl2/Cx3cr1 double knockout mice and in Cx3cr1 knockout mice, though less so in the latter.
“Macrophage and microglial accumulation was also increased relative to wild-type in Ccl2−/−/Cx3cr1−/− mice, as well as in Cx3cr1−/− mice, though to a lesser degree (Ross et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ross et al., 2008 source
Not checked in the free run.
May combine two claims.
FindingcitationCcl2/Cx3cr1 double knockout mice exhibit fundoscopically visible drusen-like lesions at 4-6 weeks of age, histological AMD signs including Bruch's membrane thickening, drusen, local RPE hypopigmentation and degeneration, photoreceptor disorganization and atrophy, and CNV in some mice.
“We found that Ccl2−/−/Cx3cr1−/− mice exhibited, at an early age of 4–6 weeks, fundoscopically visible drusen-like lesions, as well as histological signs of AMD such as thickening of Bruch’s membrane, drusen, local RPE hypopigmentation and degeneration, and photoreceptor disorganization and atrophy, as well as CNV in some mice.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenAMD pathology involves degeneration of retinal photoreceptors, retinal pigment epithelium, Bruch's membrane, and in some cases choroidal capillaries.
“AMD pathology is characterized by degeneration involving the retinal photoreceptors, retinal pigment epithelium, and Bruch’s membrane, as well as, in some cases, alterations in choroidal capillaries.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAntioxidants, nuts, fish, and omega-3 polyunsaturated fatty acids have protective effects against AMD.
“analyses have revealed protective effects from antioxidants, nuts, fish, and omega-3 polysaccharide unsaturated fatty acids (AREDS, 2001; Cho et al., 2001; Seddon et al., 1994, 2001; Smith et al., 2000).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationBoth fat intake and obesity are linked to increased risk of AMD.
“Both fat intake and obesity have been linked to increased risk of AMD (Mares-Perlman et al., 1995; Seddon et al., 2003)”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
Premisenone givenEarly AMD is characterized by thickening and loss of normal architecture within Bruch's membrane, lipofuscin accumulation in the RPE, and drusen formation beneath the RPE in Bruch's membrane.
“Early AMD is characterized by thickening and loss of normal architecture within Bruch’s membrane, lipofuscin accumulation in the RPE, and drusen formation beneath the RPE in Bruch’s membrane”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAge-related changes in mouse RPE and choroid include recruitment of leukocytes and activation of the complement cascade.
“A recent study of age-related changes demonstrates recruitment of leukocytes and activation of the complement cascade in mouse RPE and choroid (Chen et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationRecurrence risks in relatives of AMD cases are increased: siblings 2.95, first cousins 1.29, second cousins 1.13, and parents 5.66.
“Recurrence risks in relatives indicate increased relative risks in siblings (2.95), first cousins (1.29), second cousins (1.13), and parents (5.66) of affected cases (Luo et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Luo et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationLarger drusen, greater area covered by drusen, and larger areas of RPE hyperpigmentation and hypopigmentation in the macula increase the risk of late AMD.
“The larger the drusen, the greater the area they cover, and the larger the areas of hyperpigmentation and hypopigmentation of the RPE in the macula, the higher the risk of late age-related macular degeneration is (Klein et al., 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Klein et al., 2002 source
Not checked in the free run.
May combine two claims.
PremisecitationAging is associated with retinal changes including alterations in RPE cell size and shape, thickening of Bruch's membrane, thickening of the internal limiting membrane, and a decrease in retinal neuronal elements.
“Aging is associated with changes in the retina, including alterations in RPE cellular size and shape, thickening of Bruch’s membrane, thickening of the internal limiting membrane, and a decrease in retinal neuronal elements (Green, 1996).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Green, 1996
Not checked in the free run.
May combine two claims.
PremisecitationBasal linear deposits consist of vesicular material in the inner collagenous zone of Bruch's membrane and represent a specific marker for AMD.
“BlinL consist of vesicular material located in the inner collagenous zone of Bruch’s membrane and represent a specific marker for AMD (Curcio and Millican, 1999).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Curcio and Millican, 1999
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRecent studies have generated significant interest in the inflammatory underpinnings of AMD pathogenesis.
“recent studies have generated significant interest in the inflammatory underpinnings of AMD pathogenesis (Klein et al., 2008b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klein et al., 2008b
Not checked in the free run.
May combine two claims.
Premisenone givenThese SNPs lie in genes encoding complement factors, chemokines and chemokine receptors, and toll-like receptors.
“These SNPs lie in genes encoding complement factors, chemokines and chemokine receptors, and toll-like receptors.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisereasoningLoss of RPE cells leads to gradual degeneration of nearby photoreceptors, thinning of the retina, and progressive visual impairment.
“Loss of RPE cells responsible for servicing the overlying photoreceptors leads to the gradual degeneration of nearby photoreceptors, resulting in thinning of the retina (Fig. 2) and a progressive visual impairment.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationRetinal angiomatous proliferation refers to new vessel development extending outward into the subretinal space from the neurosensory retina, sometimes anastomosing with choroid-derived vessels.
“RAP refers to new vessel development extending outward into the subretinal space from the neurosensory retina, sometimes anastomosing with the choroid-derived vessels (Lafaut et al., 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lafaut et al., 2000 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenClassical neovascular AMD is mainly illustrated by CNV and subretinal neovascular fibrous tissue.
“Classical neovascular AMD is mainly illustrated with CNV and subretinal neovascular fibrous tissue (Fig. 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenChoroidal neovascularization is the defining characteristic of late stage wet or neovascular AMD.
“Choroidal neovascularization (CNV) is the defining characteristic of late stage ‘wet’ or neovascular AMD.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenDrusen are the hallmark lesions of AMD.
“it has long been recognized that drusen are the hallmark lesions of AMD.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCFH inhibits the alternative pathway by promoting Factor I-mediated inactivation of C3b or by displacing Factor Bb from the C3bBb complex.
“CFH inhibits the alternative pathway by promoting Factor I-mediated inactivation of C3b or by displacing Factor Bb from the C3bBb complex (Alsenz et al., 1985).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Alsenz et al., 1985 source
Not checked in the free run.
May combine two claims.
PremisecitationYu et al. found no significant difference between Y and H CFH variants in protein secretion, cofactor activity, or heparan interaction, but a significant difference in CRP binding.
“Yu et al. also show no significant difference in their protein secretion, cofactor activity, or interaction with heparan, but a significant difference in binding to CRP (Yu et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yu et al., 2007
Not checked in the free run.
May combine two claims.
PremisecitationCFH is encoded within chromosome 1q23-32, a region previously associated with AMD through linkage studies.
“CFH is encoded within the interval of chromosome 1q23–32, a region associated with AMD previously through linkage studies (Klein et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Klein et al., 1998 source
Not checked in the free run.
May combine two claims.
PremisecitationAMD patients have increased serum anti-C. pneumoniae antibodies, and these antibodies are linked to increased risk of AMD progression.
“AMD patients have been found to possess increased serum anti-C. pneumoniae antibodies, and these antibodies have been linked to increased risk of AMD progression (Robman et al., 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Robman et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationCFH binds to denatured rather than native CRP, casting doubt on the link between CFH and CRP.
“a recent publication indicates that CFH binds to the denatured rather than native CRP, thus casting some doubt upon this link between CFH and CRP (Hakobyan et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hakobyan et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationThe L9H BF/E318D C2 and R32Q BF/intronic C2 variants are protective for AMD, with odds ratios of 0.45 and 0.36, respectively.
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gold et al., 2006 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningCurrent data suggest a central role for innate immunity and inflammation in general, and complement overactivation in particular, in AMD pathogenesis.
“the current data suggest a central role for innate immunity and inflammation in general and complement overactivation in particular for AMD pathogenesis.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn AREDS patients, an interaction was observed between CFH Y402H genotype and antioxidant plus zinc supplementation: in YY homozygotes, 34% of placebo-treated progressed to advanced AMD versus 11% of antioxidant-plus-zinc-treated; in HH homozygotes, 44% of placebo-treated progressed versus 39% of treated.
“In individuals homozygous for the non-risk phenotype (Y402Y/Y402Y), 34% of those treated with placebo progressed to advanced AMD, compared with 11% of those treated with antioxidants plus zinc, a reduction of approximately 68%. In contrast, in individuals homozygous for the risk-conferring phenotype (Y402H/Y402H), 44% of those treated with placebo group progressed to advanced AMD, compared with 39”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Klein et al., 2008a
Not checked in the free run.
May combine two claims.
PremisecitationVariation near the FI gene on chromosome 4q25 is associated with risk of advanced AMD, although no obvious functional variation has been discovered.
“Variation near the FI gene on chromosome 4q25 is associated with risk of advanced AMD, although no obvious functional variation has been discovered (Fagerness et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fagerness et al., 2008
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationC3F has been associated with membranoproliferative glomerulonephritis type II.
“C3F has in fact been associated with several diseases, including membranoproliferative glomerulonephritis type II (Montes et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Montes et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationThe IL8 A251T genetic polymorphism is associated with AMD, with the homozygous AA genotype as the at-risk factor.
“The interleukin-8 (IL8) A251T genetic polymorphism located in chromosome 4q13–21 is reported to be associated with AMD, with the homozygous AA genotype (A allele) as the “at risk” factor (Goverdhan et al., 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Goverdhan et al., 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationCX3CR1 is expressed on all retinal microglial cells, and these cells are the only cells in the retina that express CX3CR1.
“whose immunohistochemical analysis in humans showed that CX3CR1 was expressed on all retinal microglial cells, and these cells are the only cells in the retina that express CX3CR1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe D299G TLR4 polymorphism leads to increased AMD risk, with an odds ratio of 2.65.
“A study by Zareparsi et al reported that the D299G (aspartate to glycine at amino acid 299) TLR4 (encoded in chromosome 9q32–33) polymorphism leads to increased AMD risk (OR = 2.65) (Zareparsi et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zareparsi et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationThe finding of an AMD susceptibility locus on chromosome 10q26 has been replicated by other genome-wide linkage studies and supported by a genome-scan meta-analysis.
“This finding of an AMD susceptibility locus on chromosome 10q26 has been replicated by other genome-wide linkage studies (Weeks et al., 2004) and supported by a genome-scan meta-analysis (Fisher et al., 2005).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThe D299G TLR4 variant has been linked to impaired LPS responsiveness in mice, which is reversible by TLR4 overexpression.
“Functionally, the D299G TLR4 variant has been linked to impaired LPS responsiveness in mice, which is reversible by TLR4 overexpression (Arbour et al., 2000).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Arbour et al., 2000 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe relationships between SNPs in TLR genes and AMD remain preliminary or controversial and need further studies in larger, diverse populations.
“In general, the relationships of these SNPs with AMD are still preliminary or controversial to date and require additional studies in diverse and larger populations.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitationrs11200638 in the HtrA1 promoter is the most well-documented, statistically significant AMD-associated SNP, with odds ratios of 1.60-2.61 in heterozygous and 6.56-10.0 in homozygous individuals (Caucasians, Chinese, Japanese).
“Several studies have shown that rs11200638 in the promoter region is the most well-documented, statistically significant AMD-associated SNP with a high OR of 1.60–2.61 and 6.56–10.0 in heterozygous and homozygous individuals (Caucasians, Chinese and Japanese), respectively (Cameron et al., 2007; Deangelis et al., 2008; Dewan et al., 2006; Mori et al., 2007; Tam et al., 2008; Yang et al., 2006).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationHuman donor AMD eyes contain higher levels of protein adducts from oxidative modification of carbohydrates and lipids and higher levels of antioxidant enzymes compared with non-AMD eyes.
“First, studies have shown that human donor AMD eyes contain higher levels of protein adducts resulting from the oxidative modification of carbohydrates and lipids (Crabb et al., 2002; Howes et al., 2004) and higher levels of antioxidant enzymes (Decanini et al., 2007; Frank et al., 1999) compared with non-AMD eyes, which indicate that oxidative stress plays an important role in AMD.”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningMitochondria play a central role in aging and in the pathogenesis of AMD.
“Several lines of evidence indicate that mitochondria play a central role in aging and in the pathogenesis of AMD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationARMS2 protein in the human retina localizes to the photoreceptor layer and co-localizes with a mitochondrial marker, suggesting mitochondrial expression.
“Fritsche et al. also showed that ARMS2 protein in the human retina localizes to the photoreceptor layer and that it demonstrates a minor dot-like staining in the ellipsoid region of the rod and cone inner segments, which fully co-localizes with a mitochondrial marker, anti-MTCO2, suggesting that ARMS2 is expressed in the mitochondria (Fritsche et al., 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fritsche et al., 2008 source
Not checked in the free run.
May combine two claims.
Premisenone givenThe A69S and InDel are in 100% linkage disequilibrium and on the same haplotype, so their effects are not independent.
“Most importantly, since the A69S and InDel are in 100% LD and on the same haplotype, the effects are not independent to each other.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTherapies targeting VEGF have shown significant improvement of central vision and reduction of CNV.
“VEGF plays a critical role in the pathogenesis of neovascular AMD, and recently, therapies targeting VEGF have shown promising results of significant improvement of central vision and reduction of CNV (Wylegala and Teper, 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wylegala and Teper, 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationARMS2 (A69S), rather than HtrA1, is truly associated with AMD.
“Recently Kanda et al. reported that ARMS2 (T allele at rs10490924, A69S), rather than HtrA1, to be truly associated with AMD (Kanda et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kanda et al., 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVEGF is a key molecule in promoting angiogenesis.
“It is well established that the formation of blood vessels occurs by angiogenesis and that vascular endothelial growth factor (VEGF) is a key molecule in promoting angiogenesis (Ferrara et al., 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Ferrara et al., 2003 source
Not checked in the free run.
May combine two claims.
PremisecitationThe ERCC6 C6530G SNP is modestly associated with AMD susceptibility, and its interaction with a SNP (rs380390) in the CFH intron is highly associated with AMD.
“One study has demonstrated that the ERCC6 C6530G SNP is modestly associated with AMD susceptibility, its interaction with a SNP (rs380390) in the CFH intron is highly associated with AMD (Tuo et al., 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Tuo et al., 2006 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningConflicting data on VEGF-A association with AMD could result from differences in ethnicities studied, study designs, and statistical analyses.
“These conflicting data could result from differences of the ethnicities studied, study designs, and statistical analyses.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe RPE cell is one of many systems that downregulate the immune response in the eye, and the pathway between RPE damage and ocular inflammation is likely bidirectional.
“Indeed, the RPE cell is one of many systems that downregulate the immune response in the eye, and thus the pathway between RPE damage and ocular inflammation is likely a two way street whereby RPE damage potentiates inflammation, which further worsens RPE degeneration.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNeovascular AMD is associated with the rs2010963 (G634C) VEGF-A SNP and with two intronic VEGF-A SNPs (rs833070 and rs3025030).
“Neovascular AMD was found to be associated with the rs2010963 (G634C) VEGF-A SNP in a case-control cohort, and in a family cohort with two intronic VEGF-A SNPs (rs833070 and rs3025030) (Haines et al., 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Haines et al., 2006 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenThe mouse retina has no macula.
“The main drawback of using mice to study AMD is that the mouse retina has no macula.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCx3cr1 knockout mice show increased microglial accumulation after laser injury, worsened laser-induced CNV, and retinal degeneration.
“Moreover, Cx3cr1−/− mice exhibited increased microglial accumulation after laser-injury, as well as worsened laser-induced CNV and retinal degeneration.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationCx3cr1 knockout mice show retinal degeneration and drusen-like deposits containing bloated microglia that can phagocytose photoreceptor outer segments in mice aged 18 months and older.
“Cx3cr1−/− mice demonstrated retinal degeneration and drusen-like deposits, which contained bloated accumulated microglia capable of phagocytosing outer segments of photoreceptor cells in 18 months and older mice.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Combadiere et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationMicroglia are resident immune cells in the retina required for neuronal homeostasis and innate immune defense.
“Microglia are the resident immune cells in the retina required for neuronal homeostasis and innate immune defense (Langmann, 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Langmann, 2007 source
Not checked in the free run.
May combine two claims.
Interpretationown dataAnimal models based on Ccl2 and Cx3cr1 knockout have strengthened the hypothesis and provided insights into potential inflammatory mechanisms underlying AMD pathogenesis.
“Animal models based upon Ccl2 and Cx3cr1 knockout have lent strength to this hypothesis and provided some insights into the potential inflammatory mechanisms underlying AMD pathogenesis.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationThese findings are consistent with human AMD drusen findings and with a critical role of complement overactivity in AMD.
“These findings are consistent with findings in drusen of humans with AMD (Hageman et al., 2005), as well as the critical role in AMD of complement overactivity, which has been discussed above.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hageman et al., 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenCFH polymorphisms are associated with susceptibility to AMD in more than half of affected individuals.
“As discussed above, CFH polymorphisms are associated with susceptibility to AMD in more than half of affected individuals.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataThe Ccl2/Cx3cr1 double knockout mouse model of AMD is robust and has several immunological features also documented in human AMD and supported by other in vivo AMD models.
“These findings highlight that the Ccl2−/−/Cx3cr1−/− murine model of AMD is a robust one with several immunological features also documented in human AMD and supported by studies in other in vivo models of AMD.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationFunduscopic examination and vasculature appear normal in cfh knockout mice.
“Funduscopic examination and vasculature, however, appears normal in the cfh−/− mice.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Coffey et al., 2007 source
Not checked in the free run.
May combine two claims.
PremisecitationCNV in aged ApoE4 mice on the high fat cholesterol rich diet contains amyloid β deposits, VEGF, and other factors also seen in human AMD and CNV.
“Moreover, CNV in aged ApoE4 mice on the HF-CR diet contained amyloid β deposits, as well as VEGF and other factors also seen in human AMD and CNV.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Malek et al., 2005 source
Not checked in the free run.
May combine two claims.
Premisecitationcfh knockout mice show increased autofluorescence, C3 accumulation, disorganization of photoreceptor outer segments, thinning of Bruch's membrane, and increased RPE organelles.
“These mice also demonstrated increased autofluorescence, accumulation of C3, and disorganization of photoreceptor outer segments in the retina, as well as thinning of Bruch’s membrane and increased RPE organelles.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Coffey et al., 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Premisenone givenPrior studies suggest a probable association between ApoE polymorphisms and AMD.
“As discussed above, prior studies have suggested a probable association between ApoE polymorphisms and AMD.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAged ApoE4 mice on a high fat cholesterol rich diet exhibit several features of human AMD, including drusen, Bruch's membrane thickening, geographic RPE atrophy, and CNV.
“Aged ApoE4 mice on this diet exhibited several features of human AMD, including drusen, thickening of Bruch’s membrane, geographic RPE atrophy, and CNV.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Malek et al., 2005 source
Not checked in the free run.
May combine two claims.
PremisecitationEyes of ApoE2 transgenic mice express higher levels of VEGF and lower levels of PEDF.
“Moreover, the eyes of ApoE2 transgenic mice also expressed higher levels of the proangiogenic factor VEGF but lower levels of anti-angiogenic factor pigment epithelium derived factor (PEDF).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee et al., 2007
Not checked in the free run.
May combine two claims.
PremisecitationAbcr knockout mice demonstrate decreased dark adaptation, increased all-trans-retinaldehyde after light exposure, increased phosphatidylethanolamine in outer segments, accumulation of N-retinylidene-phosphatidylethanolamine in photoreceptors, and deposition of A2E fluorophore in the RPE.
“Abcr−/− mice demonstrate decreased dark adaptation, increased all-trans-retinaldehyde after light exposure, increased phosphatidylethanolamine (PE) in outer segments, accumulation of N-retinylidene-phosphatidylethanolamine, the conjugate of all-trans retinaldehyde and PE in photoreceptors, and deposition of A2E fluorophore, a major component of lipofuscin, in the RPE (Weng et al., 1999).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Weng et al., 1999 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe ApoE-based murine model of AMD highlights a potential role for cholesterol metabolism in AMD pathogenesis and emphasizes the need to clarify the role of ApoE variants in human AMD.
“Most importantly, the ApoE-based murine model of AMD highlights the potential role for cholesterol metabolism in AMD pathogenesis and further emphasized the need to clarify the role of ApoE variants in human AMD.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Premisenone givenAlthough age, race, smoking, and diet have been linked to AMD, the etiology and pathogenesis of the disease remain largely unclear.
“While several risk factors, including age, race, smoking, and diet have been linked to AMD, the etiology and pathogenesis of the disease remain largely unclear.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
Premisenone givenOur understanding of AMD pathogenesis remains largely incomplete.
“Though AMD research has made great advances in recent years, our understanding of its pathogenesis remains largely incomplete.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenCFH polymorphisms have been linked to a pro-inflammatory state, including increased CRP and decreased complement inhibitory effect.
“CFH polymorphisms have been linked to a pro-inflammatory state, including increased CRP and decreased complement inhibitory effect.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenVEGF is a key angiogenic factor in the development of CNV in late stage AMD, and recent studies suggest that VEGF gene polymorphisms might contribute to AMD risk and to efficacy of anti-VEGF therapy.
“VEGF is a key angiogenic factor in the development of CNV in late stage AMD, and recent studies suggest that polymorphisms in the VEGF gene might contribute to risk of AMD and to efficacy of anti-VEGF therapy.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningEpidemiological studies strengthen the role of oxidative stress by showing increased AMD risk with smoking and decreased risk with antioxidant-rich diets such as lutein/zeaxanthin.
“The role of oxidative stress is further strengthened by epidemiological studies demonstrating increased risk with smoking, a potent oxidizing stress, and decreased risk with diets rich in antioxidants such as lutein/zeaxanthin.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenTreatment options for AMD are limited.
“Treatment options for the condition are similarly limited.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenAMD lesions classically show signs of persistent chronic inflammatory damage, including mild macrophage infiltration, microglial accumulation, and inflammatory components such as complement factors and pro-inflammatory cytokines/chemokines in drusen and AMD lesions.
“Pathology of AMD lesions classically demonstrates signs of persistent chronic inflammatory damage, including not only mild infiltration of macrophages and accumulation of microglia, but also presence of inflammatory components such as complement factors and pro-inflammatory cytokines/chemokines in the drusen and AMD lesions.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenAMD is a debilitating retinal disease that manifests clinically with loss of central vision and pathologically with drusen accumulation, RPE degeneration, photoreceptor atrophy, and in some cases CNV.
“AMD is a debilitating disease of the retina, which manifests clinically with loss of central vision and pathologically with the accumulation of drusen, RPE degeneration, photoreceptor atrophy, and in some cases, with CNV.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationUltrastructural analysis reveals abnormal basal RPE with small irregular dense bodies in both abcr knockout and heterozygous mice, but no drusen formation.
“Ultrastructural analysis revealed abnormal basal RPE with small irregular dense bodies in both abcr−/− and abcr+/− mice, but no drusen formation (Mata et al., 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mata et al., 2001
Not checked in the free run.
The paper relies on this without support.
Innovation in AMD pharmacotherapy depends largely on a thorough understanding of the molecular mechanisms underlying AMD pathogenesis.
“Innovation in AMD pharmacotherapy, in turn, depends largely upon a thorough understanding of the molecular mechanisms underlying AMD pathogenesis.”
The paper relies on this without support.
AMD is a multifactorial disease that primarily affects photoreceptors and RPE cells.
“AMD is a multifactorial disease that affects primarily the photoreceptors and RPE cells.”
The paper relies on this without support.
The mouse retina has no macula.
“The main drawback of using mice to study AMD is that the mouse retina has no macula.”
The paper relies on this without support.
Laser-induced CNV and CNV associated with age-related degenerative retinal changes arise through different mechanisms.
“These studies might be reconciled by the argument that laser-induced CNV, an acute injury, occurs by a different mechanism than CNV associated with age-related degenerative changes in the retina.”
The paper relies on this without support.
Many critical biological processes are context specific.
“Given the context specificity of many critical biological processes and the fact that most common diseases including AMD are thought to be the outcome of a complex interaction between many genetic loci and the environment, it follows that there are obvious advantages to studying gene expression in cells and tissues that represent the in vivo state.”
The paper relies on this without support.
Common diseases including AMD result from complex interactions between many genetic loci and the environment.
“Given the context specificity of many critical biological processes and the fact that most common diseases including AMD are thought to be the outcome of a complex interaction between many genetic loci and the environment, it follows that there are obvious advantages to studying gene expression in cells and tissues that represent the in vivo state.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The four SNPs studied have consistently shown the strongest associations with AMD development and progression and have been postulated to influence treatment response.
“Although other susceptibility genes have been reported, these four SNPs have consistently been shown to have the strongest associations with the development and progression of AMD and have been postulated to influence response to therapy.2,3,12”
From Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT) (2013) · cites this paper as [2]
Sections 3.2 and 3.4 report strong associations of particular CFH, ARMS2, and HtrA1 variants with AMD risk, and section 7 reports that a risk-conferring CFH variant was associated with reduced response to antioxidant and zinc therapy. The paper does not establish that the citing study’s four SNPs, as a group, consistently have the strongest associations with both AMD development and progression or that all four may influence treatment response. No page numbers were provided in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measuredNumerous SNPs in multiple genes have been associated with the prevalence of early and/or late AMD.
“Pioneering developments in AMD genetics research have identified numerous single nucleotide polymorphisms (SNPs) in multiple genes associated with the prevalence of the early and/or late stages of AMD.2,3”
From Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT) (2013) · cites this paper as [2]
Overexpression of HTRA1 has been hypothesized to alter Bruch's membrane integrity and favor CNV development.
“It has been hypothesized that overexpression of HTRA1 may alter the integrity of Bruch’s membrane and favor the development of CNV.2”
From Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT) (2013) · cites this paper as [2]
Loss of mitochondria is reported in AMD retina.
“Loss of mitochondria is also reported in AMD retina (Ding et. al, 2009).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Ding et. al, 2009
AMD still has an unknown etiology, though oxidative stress to RPE cells along with immune dysregulation are leading theories of AMD pathogenesis.
“AMD still has an unknown etiology, though oxidative stress to the retinal pigment epithelium (RPE) cells along with immune dysregulation are leading theories of AMD pathogenesis (Ding et al., 2009).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Ding et al., 2009
There is an age-related increase in thickness in Bruch's membrane and the internal limiting membrane.
“There is an age-related increase in thickness in Bruch’s membrane and the internal limiting membrane (Sarks, 1976; Ding et al., 2009).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Ding et al., 2009
The Ccl2−/−/Cx3cr1−/− mouse model demonstrates many AMD features: small drusenoid deposits, RPE and Bruch's membrane degenerations, photoreceptor atrophy, CNV, and simulation of the immunologic and pathologic environments found in AMD patients.
“The Ccl2−/−/Cx3cr1−/− mouse model demonstrates many AMD features: small drusenoid deposits, RPE and Bruch’s membrane degenerations, photoreceptor atrophy, CNV, and simulation of the immunologic and pathologic environments found in AMD patients (Herzlich et al., 2008; Ross et al., 2008; Ding et al., 2009).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Ding et al., 2009
The molecular pathology of dry AMD has demonstrated a role of oxidative stress, inflammation, and metabolic dysregulation.
“The molecular pathology of dry AMD has demonstrated a role of oxidative stress, inflammation, and metabolic dysregulation”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Ding et al. 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Brantley study's treatment differs from its reference title
MinorThe text attributes a bevacizumab treatment-response analysis to Brantley et al., while the cited reference identifies the treatment as photodynamic therapy.
“Brantley et al. investigated 86 wet AMD patients to determine whether there is an association between CFH genotypes and response to treatment with intravitreal bevacizumab.”
“19. Brantley MA Jr Edelstein SL King JM Plotzke MR Apte RS Kymes SM Shiels A Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy Eye 2008”
Cites
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591 · cited 2× · see citing works
“VEGF It is well established that the formation of blood vessels occurs by angiogenesis and that vascular endothelial growth factor (VEGF) is a key molecule in promoting angiogenesis (Ferrara et al., 2003).”
BackgroundThe chemokine system in diverse forms of macrophage activation and polarization
MANTOVANI, A., SICA, A., SOZZANI, S., ALLAVENA, P., VECCHI, A., & LOCATI, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.015 · Cited by 6,534 · cited 3× · see citing works
“A dual role for macrophages in AMD—Another plausible explanation for these seemingly contradictory findings is that macrophages comprise a heterogeneous group with a spectrum of phenotypes and activities (Mantovani et al., 2004).”
BackgroundResultInfluentialRanibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886 · see citing works
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492 · see citing works
(2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.10.1417 · Cited by 3,285 · see citing works
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,921 · cited 1× · see citing works
“…of the complement system generates a variety of pro-inflammatory responses, including the production of membrane-attack complexes (MAC) which lead to cell lysis, release of chemokines to mediate recruitment of inflammatory cells, and enhancement of capillary permeability (Walport, 2001a, b).”
BackgroundPrevalence of Age-Related Macular Degeneration in the United States
The Eye Diseases Prevalence Research Group* (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,742 · cited 2× · see citing works
“Currently, in the United States alone, 1.75 million people are affected by AMD and 7 million people are at risk of developing AMD (Friedman et al., 2004).”
BackgroundInfluentialComplement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449 · cited 4× · see citing works
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
BackgroundInfluentialComplement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424 · cited 4× · see citing works
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
BackgroundInfluentialPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1× · see citing works
“…Inhibition Study in Ocular Neovascularization, Clinical Trial and Minimally Classic/Occult Trial of the Anti-VEGF Antibody Ranibizumab in the Treatment of Neovascular Age-Related Macular Degeneration (MARINA) (AREDS, 2001; Bressler et al., 2003; Gragoudas et al., 2004; Rosenfeld et al., 2006).”
BackgroundWiklund, R. A., & Rosenbaum, S. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371606 · Cited by 2,159 · see citing works
Interleukin-8 as a macrophage-derived mediator of angiogenesis
Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., & Strieter, R. M. (1992) · Science · doi:10.1126/science.1281554 · Cited by 2,135 · cited 1× · see citing works
“The AA genotype has also been shown to induce angiogenesis in rat cornea (Koch et al., 1992).”
BackgroundTLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024 · cited 1× · see citing works
“Functionally, the D299G TLR4 variant has been linked to impaired LPS responsiveness in mice, which is reversible by TLR4 overexpression (Arbour et al., 2000).”
BackgroundHageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961 · cited 3× · see citing works
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441506 · Cited by 1,480 · cited 1× · see citing works
“…of the complement system generates a variety of pro-inflammatory responses, including the production of membrane-attack complexes (MAC) which lead to cell lysis, release of chemokines to mediate recruitment of inflammatory cells, and enhancement of capillary permeability (Walport, 2001a, b).”
BackgroundAllikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435 · cited 2× · see citing works
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript one allele of the gene in 16% of the AMD patients (Allikmets, 1997; Allikmets et al., 1997).”
BackgroundAge-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379 · see citing works
Genetics of gene expression and its effect on disease
Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G. B., Gunnarsdottir, S., et al. (2008) · Nature · doi:10.1038/nature06758 · Cited by 1,296 · cited 1× · see citing works
“…on the expression of 23,720 transcripts from trials on blood samples (n = 1002) or adipose tissue (n = 673), findings from over 50% of trials in adipose samples correlated to those from clinical trials related to obesity, compared to less than 10% in trials on blood samples (Emilsson et al., 2008).”
BackgroundThe highways and byways of mRNA decay
Garneau, N. L., Wilusz, J., & Wilusz, C. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2104 · Cited by 1,294 · cited 1× · see citing works
“The insertion introduces a 54-bp AU-rich element, known for its properties to control mRNA decay in many transcripts that encode a wide variety of proteins involved in transient biological processes (Barreau et al., 2005; Garneau et al., 2007; Khabar, 2005).”
BackgroundHageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265 · cited 2× · see citing works
“The molecular and cellular constituents of drusen have been analyzed extensively (Anderson et al., 2004; Crabb et al., 2002; Hageman et al., 2001; Johnson et al., 2000; Mullins et al., 2000; Russell et al., 2000).”
BackgroundDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208 · cited 5× · see citing works
“…of studies have illustrated the presence of complement components and complement regulatory proteins in drusen and nearby RPE of AMD patients (Crabb et al., 2002; Hageman et al., 1999; Johnson et al., 2001; Johnson et al., 2000; Mullins et al., 2001; Nozaki et al., 2006), suggesting a role…”
BackgroundInfluentialThe Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, R., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,148 · cited 1× · see citing works
“The larger the drusen, the greater the area they cover, and the larger the areas of hyperpigmentation and hypopigmentation of the RPE in the macula, the higher the risk of late age-related macular degeneration is (Klein et al., 2002).”
BackgroundThe AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075 · cited 1× · see citing works
“BF is a complement activating factor, and studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
BackgroundAU-rich elements and associated factors: are there unifying principles?
Barreau, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki1012 · Cited by 1,033 · cited 1× · see citing works
“The insertion introduces a 54-bp AU-rich element, known for its properties to control mRNA decay in many transcripts that encode a wide variety of proteins involved in transient biological processes (Barreau et al., 2005; Garneau et al., 2007; Khabar, 2005).”
BackgroundLu, B., RUTLEDGE, B. J., Gu, L., Fiorillo, J., Lukacs, N. W., Kunkel, S. L., North, R. J., Gerard, C. J., & Rollins, B. J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.4.601 · Cited by 1,017 · cited 1× · see citing works
“CCL2 or CCR2 deficiency leads to impaired accumulation of macrophages at sites of inflammation (Kuziel et al., 1997; Lu et al., 1998).”
BackgroundDietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
Seddon, J. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520180037032 · Cited by 993 · cited 1× · see citing works
“…been linked to increased risk of AMD (Mares-Perlman et al., 1995; Seddon et al., 2003), and analyses have revealed protective effects from antioxidants, nuts, fish, and omega-3 polysaccharide unsaturated fatty acids (AREDS, 2001; Cho et al., 2001; Seddon et al., 1994, 2001; Smith et al., 2000).”
BackgroundMullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937 · cited 3× · see citing works
“Immunohistochemical analyses have shown various molecular constituents, such as apolipoproteins B and E, different immunoglobulins, factor X, amyloid P component, amyloid β, complement C5 and C5b-9 terminal complexes, fibrinogen, vitronectin, and others, to be present in all phenotypes of hard and soft drusen (Anderso…”
BackgroundWeng, J., Mata, N. L., Azarian, S. M., Tzekov, R. T., Birch, D. G., & Travis, G. H. (1999) · Cell · doi:10.1016/s0092-8674(00)80602-9 · Cited by 881 · cited 4× · see citing works
“These processes might therefore contribute to impaired RPE function and subsequent RPE and photoreceptor degeneration (Weng et al., 1999).”
BackgroundInfluentialMutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
Allikmets, R. L., Shroyer, N. F., Singh, N., Seddon, J. M., Lewis, R. A., Bernstein, P. S., Peiffer, A. P., Zabriskie, N. A., Li, Y., Hutchinson, A. A., et al. (1997) · Science · doi:10.1126/science.277.5333.1805 · Cited by 879 · see citing works
<i>HTRA1</i> Promoter Polymorphism in Wet Age-Related Macular Degeneration
DeWan, A., Liu, M., Hartman, S., Zhang, S. S.-M., Liu, D. T. L., Zhao, C., Tam, P. O. S., Chan, W. M., Lam, D. S. C., Snyder, M., et al. (2006) · Science · doi:10.1126/science.1133807 · Cited by 876 · see citing works
FERRARA, N., DAMICO, L., SHAMS, N., LOWMAN, H., & KIM, R. (2006) · Retina · doi:10.1097/01.iae.0000242842.14624.e7 · Cited by 849 · cited 1× · see citing works
“Pegaptanib (macugen), an oligonucleotide aptamer that targets the VEGF165 isoform, and ranibizumab (Lucentis) and bevacizumab (Avastin), both monoclonal antibodies against VEGF-A, are currently employed in AMD therapy (Ferrara et al., 2006; Kaiser, 2006).”
MethodComplement C3 variant and the risk of age-related macular degeneration
Yates, J. R. W., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072618 · Cited by 829 · cited 1× · see citing works
“In contrast, the fast migrating allotype (C3F), has been reported to be strongly associated with AMD in a study from English and Scottish populations (Yates et al., 2007).”
BackgroundA Variant of the <i>HTRA1</i> Gene Increases Susceptibility to Age-Related Macular Degeneration
Yang, Z., Camp, N. J., Sun, H., Tong, Z., Gibbs, D., Cameron, D. J., Chen, H., Zhao, Y., Pearson, E., Li, X., et al. (2006) · Science · doi:10.1126/science.1133811 · Cited by 796 · cited 4× · see citing works
“…M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript HtrA1 mRNA and/or protein in the drusen and CNV components in AMD patients carrying the AA risk genotype has been reported in several studies (Cameron et al., 2007; Chan et al., 2007; Tuo et al., 2008; Yang et al., 2006) (Fig.”
BackgroundResultInfluentialRivera, A., Fisher, S. A., Fritsche, L. G., Keilhauer, C. N., Lichtner, P., Meitinger, T., & Weber, B. H. F. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi353 · Cited by 788 · see citing works
Age-related macular degeneration
de Jong, P. T. V. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062326 · Cited by 787 · cited 1× · see citing works
“Hyperpigmentary changes associated with compensatory RPE cell proliferation are frequently observed at the periphery of these hypopigmented areas (de Jong, 2006).”
BackgroundAge-related Macular Degeneration Histopathologic Studies
Green, W. R., & Enger, C. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31466-1 · Cited by 757 · cited 1× · see citing works
“The earliest pathological changes are the appearance of basal laminar deposits (BlamD) and basal linear deposits (BlinL) (Green and Enger, 1993).”
BackgroundKuziel, W. A., Morgan, S. J., Dawson, T. C., Griffin, S., Smithies, O., Ley, K. F., & Maeda, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12053 · Cited by 709 · cited 1× · see citing works
“CCL2 or CCR2 deficiency leads to impaired accumulation of macrophages at sites of inflammation (Kuziel et al., 1997; Lu et al., 1998).”
BackgroundFong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1413 · Cited by 682 · cited 1× · see citing works
“When bound by its ligand, CX3CL1 (also known as fractalkine), CX3CR1 mediates mobilization of leukocytes to inflamed tissues and subsequent activation of these inflammatory cells (Fong et al., 1998).”
BackgroundRETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION
Yannuzzi, L. A., Negrão, S., Iida, T., CARVALHO, C., Rodriguez-Coleman, H., Slakter, J. S., Freund, K. B., Sorenson, J. A., Orlock, D. A., & Borodoker, N. (2012) · Retina · doi:10.1097/iae.0b013e31823f9b3b · Cited by 660 · cited 2× · see citing works
“…mainly from the retinal circulation in a process that has been called retinal angiomatous proliferations (RAP), also called deep retinal vascular anomalous complex or retinochoroidal anastomosis (Brancato et al., 2002;Donati et al., 2006;Ghazi, 2002;Hunter et al., 2004;Yannuzzi et al., 2001).”
BackgroundRETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION
Yannuzzi, L. A., Negrão, S., Iida, T., CARVALHO, C., Rodriguez-Coleman, H., Slakter, J. S., Freund, K. B., Sorenson, J. A., Orlock, D. A., & Borodoker, N. (2001) · Retina · doi:10.1097/00006982-200110000-00003 · Cited by 658 · see citing works
Drusen complement components C3a and C5a promote choroidal neovascularization
Nozaki, M., Raisler, B. J., Sakurai, E., Sarma, J. V., Barnum, S. R., Lambris, J. D., Chen, Y., Zhang, K., Ambati, B. K., Baffi, J. Z., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408835103 · Cited by 650 · see citing works
Clausen, T., Southan, C., & Ehrmann, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00658-5 · Cited by 640 · cited 2× · see citing works
“It is also possible that ARMS2 and its pathway may be linked to mitochondrial oxidative stress, while HtrA1 and its pathway may be involved in the regulation of cell survival via chaperon/proteases (Clausen et al., 2002), and the inhibition of immune response via TGF-β (Launay et al.”
BackgroundAge‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 633 · cited 1× · see citing works
“Among the elderly, AMD is regarded as the leading cause of blindness in the world (Gehrs et al., 2006).”
BackgroundAn animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice
Ambati, J., Anand, A., Fernandez, S., Sakurai, E., Lynn, B. C., Kuziel, W. A., Rollins, B. J., & Ambati, B. K. (2003) · Nature Medicine · doi:10.1038/nm950 · Cited by 631 · cited 1× · see citing works
“Indeed, a murine model of Ccl2 or Ccr2 deficiency leads to decreased accumulation of macrophages in the retina, as well as key features of AMD including drusen (Ambati et al., 2003).”
BackgroundJohnson, L. V., Leitner, W. P., Staples, M. K., & Anderson, D. H. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1094 · Cited by 621 · cited 2× · see citing works
“…of complement components and complement regulatory proteins in drusen and nearby RPE of AMD patients (Crabb et al., 2002; Hageman et al., 1999; Johnson et al., 2001; Johnson et al., 2000; Mullins et al., 2001; Nozaki et al., 2006), suggesting a role for complement in AMD pathogenesis (Bora et…”
BackgroundCombadière, C., Feumi, C., Raoul, W., Keller, N., Rodéro, M., Pézard, A., Lavalette, S., Houssier, M., Jonet, L., Picard, E., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31692 · Cited by 618 · cited 8× · see citing works
“…bloated microglial cells and drusen deposits, presence of organelles in drusen, and the fact that microglial cells can express some of the components commonly identified in drusen as evidence that drusen in AMD might involve, at least in part, accumulated microglial cells (Combadiere et al., 2007).”
BackgroundInfluentialGupta, N., Brown, K. E., & Milam, A. H. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(02)00332-9 · Cited by 582 · cited 1× · see citing works
“Indeed, histological analysis of AMD retinas has depicted the presence of many activated microglia in the macular lesions (Gupta et al., 2003).”
BackgroundAge-related macular degeneration
Coleman, H. R., Chan, C.-C., Ferris, F. L., & Chew, E. Y. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61759-6 · Cited by 542 · see citing works
Self-citationPickering, M. C., Cook, H. T., Warren, J. A., Bygrave, A. E., Moss, J., Walport, M. J., & Botto, M. (2002) · Nature Genetics · doi:10.1038/ng912 · Cited by 516 · see citing works
Increased expression of angiogenic growth factors in age-related maculopathy
Kliffen, M., SHARMA, H. S., Mooy, C. M., KERKVLIET, S., & de Jong, P. T. V. M. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.2.154 · Cited by 501 · cited 1× · see citing works
“Increased expression of VEGF-A in the RPE and in the outer nuclear layer is reported in post-mortem maculae obtained from individuals with AMD (Kliffen et al., 1997).”
BackgroundMacrophage Depletion Inhibits Experimental Choroidal Neovascularization
Sakurai, E., Anand, A., Ambati, B. K., van Rooijen, N., & Ambati, J. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0097 · Cited by 498 · cited 1× · see citing works
“Espinosa-Heidmann et al. (2003) and Sakurai et al. (2003) and their colleagues showed that when administered to mice, these liposomes markedly impaired macrophage recruitment to areas of laser retinal injury.”
BackgroundGenetic Association of Apolipoprotein E with Age-Related Macular Degeneration
Klaver, C. C. W., Kliffen, M., van Duijn, C. M., Hofman, A., Cruts, M., Grobbee, D. E., van Broeckhoven, C., & de Jong, P. T. V. M. (1998) · The American Journal of Human Genetics · doi:10.1086/301901 · Cited by 498 · cited 4× · see citing works
“Based upon this fact, Klaver et al. have speculated that an active biosynthesis of ApoE is required to support the high rate of photoreceptor renewal in the macular region (Klaver et al., 1998).”
BackgroundInfluentialMicroglia activation in retinal degeneration
Langmann, T. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0207114 · Cited by 496 · cited 3× · see citing works
“Microglia Microglia are the resident immune cells in the retina required for neuronal homeostasis and innate immune defense (Langmann, 2007).”
BackgroundInfluentialSusceptibility genes for age-related maculopathy on chromosome 10q26
Jakobsdottir, J., Conley, Y. P., Weeks, D. E., Mah, T. S., Ferrell, R. E., & Gorin, M. B. (2005) · The American Journal of Human Genetics · doi:10.1086/444437 · Cited by 470 · cited 4× · see citing works
“Our data, including a population-based study (Wang et al., 2008), and data by Jakobsdottir and colleagues (Jakobsdottir et al., 2005) have both shown that the frequency of the ARMS2 risk allele is higher in patients with advanced AMD than in those with early or intermediate AMD.”
BackgroundResultInfluentialJohnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192203399 · Cited by 447 · cited 1× · see citing works
“Complement components, other inflammatory molecules, lipids, lipoproteins B and E, and glycoproteins are common constituents of ocular drusen (Johnson et al., 2002).”
BackgroundBlue Light Induces Mitochondrial DNA Damage and Free Radical Production in Epithelial Cells
Godley, B. F., Shamsi, F. A., Liang, F.-Q., Jarrett, S. G., Davies, S., & Boulton, M. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502194200 · Cited by 443 · cited 1× · see citing works
“Blue light irradiation and treatment with hydrogen peroxide cause long-lasting mtDNA but not nuclear DNA mutations in cultured RPE cells (Ballinger et al., 1999; Godley et al., 2005).”
BackgroundKanda, A., Chen, W., Othman, M., Branham, K. E. H., Brooks, M., Khanna, R., He, S., Lyons, R., Abecasis, G. R., & Swaroop, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703933104 · Cited by 441 · cited 6× · see citing works
“ARMS2 SNP and AMD—The association of ARMS2 gene with AMD, especially advanced AMD, susceptibility has now been replicated in numbers of independent studies (Conley et al., 2006; Rivera et al., 2005; Ross et al., 2007; Schmidt et al., 2006; Seddon et al., 2007; Kanda et al., 2007).”
BackgroundResultInfluentialGrossniklaus, H. E., Ling, J. X., Wallace, T. M., Dithmar, S., Lawson, D., Cohen, C., Elner, V. M., Elner, S. G., & Sternberg, P. (2002) · PubMed · Cited by 434 · see citing works
Dietary fat and risk for advanced age-related macular degeneration
Seddon, J. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.8.1191 · Cited by 408 · cited 1× · see citing works
“…been linked to increased risk of AMD (Mares-Perlman et al., 1995; Seddon et al., 2003), and analyses have revealed protective effects from antioxidants, nuts, fish, and omega-3 polysaccharide unsaturated fatty acids (AREDS, 2001; Cho et al., 2001; Seddon et al., 1994, 2001; Smith et al., 2000).”
BackgroundEspinosa‐Heidmann, D. G., Suñer, I. J., Hernandez, E. P., Monroy, D. C., Csaky, K. G., & Cousins, S. W. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0038 · Cited by 401 · cited 1× · see citing works
“Espinosa-Heidmann et al. (2003) and Sakurai et al. (2003) and their colleagues showed that when administered to mice, these liposomes markedly impaired macrophage recruitment to areas of laser retinal injury.”
BackgroundAge-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA
Fritsche, L. G., Loenhardt, T., Janssen, A., Fisher, S. A., Rivera, A., Keilhauer, C. N., & Weber, B. H. F. (2008) · Nature Genetics · doi:10.1038/ng.170 · Cited by 400 · cited 3× · see citing works
“correlated the ARMS2 SNPs to ARMS2 expression level (Fritsche et al., 2008).”
BackgroundInfluentialMitochondrial alterations of retinal pigment epithelium in age-related macular degeneration
Feher, J., Kovacs, I., Artico, M., Cavallotti, C., Papale, A., & Balacco Gabrieli, C. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.05.012 · Cited by 388 · cited 2× · see citing works
“Similar to findings by Feher and colleagues (Feher et al., 2006), we have also found a drastic decrease in normal mitochondria in the photoreceptors and RPE cells of the AMD eyes as compared to that of the normal age-control eyes (Fig.”
BackgroundResultBasal Linear Deposit and Large Drusen Are Specific for Early Age-Related Maculopathy
Curcio, C. A. (1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.3.329 · Cited by 388 · cited 1× · see citing works
“BlinL consist of vesicular material located in the inner collagenous zone of Bruch’s membrane and represent a specific marker for AMD (Curcio and Millican, 1999).”
BackgroundSeddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1728 · Cited by 384 · cited 2× · see citing works
“Both fat intake and obesity have been linked to increased risk of AMD (Mares-Perlman et al., 1995; Seddon et al., 2003), and analyses have revealed protective effects from antioxidants, nuts, fish, and omega-3 polysaccharide unsaturated fatty acids (AREDS, 2001; Cho et al.”
BackgroundDietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration
Tan, J. S. L., Wang, J. J., Flood, V., Rochtchina, E., Smith, W., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.083 · Cited by 381 · cited 2× · see citing works
“A recent population-based cohort study in Australia (Tan et al., 2008) demonstrated that high dietary lutein and zeaxanthin intake reduced the risk of long-term incident AMD and that high beta-carotene intake was associated with an increased risk of AMD.”
BackgroundAssociation Between C-Reactive Protein and Age-Related Macular Degeneration
Keenan, T. D. L., & Chew, E. Y. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2210 · Cited by 378 · see citing works
Association between C-reactive protein and age-related macular degeneration
Seddon, J. M. (2004) · JAMA · doi:10.1001/jama.291.6.704 · Cited by 376 · see citing works
Potential Public Health Impact of Age-Related Eye Disease Study Results: AREDS Report No. 11
(2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.11.1621 · Cited by 374 · see citing works
Klein, R., Klein, B. E. K., Tomany, S. C., Meuer, S. M., & Huang, G.-H. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01146-6 · Cited by 363 · cited 1× · see citing works
“The larger the drusen, the greater the area they cover, and the larger the areas of hyperpigmentation and hypopigmentation of the RPE in the macula, the higher the risk of late age-related macular degeneration is (Klein et al., 2002).”
BackgroundVariation near complement factor I is associated with risk of advanced AMD
Fagerness, J. A., Maller, J. B., Neale, B. M., Reynolds, R. C., Daly, M. J., & Seddon, J. M. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.140 · Cited by 357 · cited 1× · see citing works
“Variation near the FI gene on chromosome 4q25 is associated with risk of advanced AMD, although no obvious functional variation has been discovered (Fagerness et al., 2008).”
BackgroundA potential role for immune complex pathogenesis in drusen formation
JOHNSON, L. V., OZAKI, S., STAPLES, M. K., ERICKSON, P. A., & ANDERSON, D. H. (2000) · Experimental Eye Research · doi:10.1006/exer.1999.0798 · Cited by 353 · cited 5× · see citing works
“…components and complement regulatory proteins in drusen and nearby RPE of AMD patients (Crabb et al., 2002; Hageman et al., 1999; Johnson et al., 2001; Johnson et al., 2000; Mullins et al., 2001; Nozaki et al., 2006), suggesting a role for complement in AMD pathogenesis (Bora et al., 2008).”
BackgroundInfluentialProspective study of dietary fat and the risk of age-related macular degeneration
Cho, E., Hung, S., Willett, W. C., Spiegelman, D., Rimm, E. B., Seddon, J. M., Colditz, G. A., & Hankinson, S. E. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.209 · Cited by 350 · cited 2× · see citing works
“…been linked to increased risk of AMD (Mares-Perlman et al., 1995; Seddon et al., 2003), and analyses have revealed protective effects from antioxidants, nuts, fish, and omega-3 polysaccharide unsaturated fatty acids (AREDS, 2001; Cho et al., 2001; Seddon et al., 1994, 2001; Smith et al., 2000).”
BackgroundHtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins
Oka, C., Tsujimoto, R., Kajikawa, M., Koshiba‐Takeuchi, K., Ina, J., Yano, M., Tsuchiya, A., Ueta, Y., Soma, A., Kanda, H., et al. (2004) · Development · doi:10.1242/dev.00999 · Cited by 335 · cited 4× · see citing works
“HtrA1 is also a secretory protein and an inhibitor of TGFβ family member (Oka et al., 2004).”
BackgroundInfluentialSchmidt, S., Hauser, M. A., Scott, W. K., Postel, E. A., Agarwal, A., Gallins, P., Wong, F., Chen, Y. S., Spencer, K., Schnetz-Boutaud, N., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503822 · Cited by 335 · cited 17× · see citing works
“[PubMed: 17909628] Conley YP, Jakobsdottir J, Mah T, Weeks DE, Klein R, Kuller L, Ferrell RE, Gorin MB. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses.”
ResultInfluentialAssociation of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration
Seddon, J. M., Francis, P. J., George, S., Schultz, D. W., Rosner, B., & Klein, M. L. (2007) · JAMA · doi:10.1001/jama.297.16.1793 · Cited by 330 · cited 3× · see citing works
“ARMS2 SNP and AMD—The association of ARMS2 gene with AMD, especially advanced AMD, susceptibility has now been replicated in numbers of independent studies (Conley et al., 2006; Rivera et al., 2005; Ross et al., 2007; Schmidt et al., 2006; Seddon et al., 2007; Kanda et al., 2007).”
BackgroundResultRegulation of complement activation by C-reactive protein
Mold, C., Gewurz, H., & Du Clos, T. W. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00007-7 · Cited by 326 · cited 1× · see citing works
“Moreover, elevated serum level of CRP has been shown to be associated with AMD (Mold et al., 1999; Seddon et al., 2004).”
BackgroundAge‐related Macular Degeneration (AMD)
(2008) · Springer eBooks · doi:10.1007/978-3-540-38918-7_5059 · Cited by 322 · see citing works
Anderson, D. H., Talaga, K. C., Rivest, A. J., Barron, E., Hageman, G. S., & Johnson, L. V. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2003.10.011 · Cited by 319 · cited 3× · see citing works
“Immunohistochemical analyses have shown various molecular constituents, such as apolipoproteins B and E, different immunoglobulins, factor X, amyloid P component, amyloid b, complement C5 and C5b-9 terminal complexes, fibrinogen, vitronectin, and others, to be present in all phenotypes of hard and soft drusen (Anderso…”
BackgroundHistopathology of Age-Related Macular Degeneration
Lim, J. I. (2007) · CRC Press eBooks · doi:10.3109/9781420019865-6 · Cited by 310 · see citing works
Dietary fat and age-related maculopathy
Mares-Perlman, J. A. (1995) · Archives of Ophthalmology · doi:10.1001/archopht.1995.01100060069034 · Cited by 298 · cited 2× · see citing works
“Both fat intake and obesity have been linked to increased risk of AMD (Mares-Perlman et al., 1995; Seddon et al., 2003), and analyses have revealed protective effects from antioxidants, nuts, fish, and omega-3 polysaccharide unsaturated fatty acids (AREDS, 2001; Cho et al.”
BackgroundSouied, E. H., Benlian, P., Amouyel, P., Feingold, J., Lagarde, J.-P., Munnich, A., Kaplan, J., Coscas, G., & Soubrane, G. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80146-9 · Cited by 292 · cited 2× · see citing works
“Several studies later confirmed a role for ApoE SNP in AMD (Baird et al., 2006; Jun et al., 2005; Kovacs et al., 2007; Schmidt et al., 2002; Souied et al., 1998; Zareparsi et al., 2004), while others found no effect (Kaur et al.”
BackgroundThe Role of Human HtrA1 in Arthritic Disease
Grau, S., Richards, P. J., Kerr, B. C., Hughes, C., Caterson, B., Williams, A. S., JUNKER, U., Jones, S. A., Clausen, T., & Ehrmann, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500361200 · Cited by 290 · cited 3× · see citing works
“…may favor neovascularization by enhancing degradation of extracellular matrix components through increased expression of matrix metalloproteinases (Grau et al., 2006), or by binding to transforming growth factor (TGF)-β, an angiogenic factor whose expression has been geographically and temporally…”
BackgroundInfluentialApolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration
Malek, G., Johnson, L. V., Mace, B. E., Saloupis, P., Schmechel, D. E., Rickman, D. W., Toth, C. A., Sullivan, P. M., & Rickman, C. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503015102 · Cited by 284 · see citing works
Xu, H., Chen, M., Manivannan, A., Lois, N., & Forrester, J. V. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2007.00351.x · Cited by 277 · cited 1× · see citing works
“The notion that microglia contribute to drusen-like deposits is further strengthened by another study demonstrating that increasing fundus autofluorescence seen in aging wild-type mice consists of perivascular and subretinal microglia, which might also contain lipofuscin granules (Xu et al., 2008).”
BackgroundTsutsumi, C., Sonoda, K.-H., Egashira, K., Qiao, H., Hisatomi, T., Nakao, S., Ishibashi, M., Charo, I. F., Sakamoto, T., Murata, T., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902436 · Cited by 277 · cited 2× · see citing works
“demonstrating that decreased macrophage influx after laser injury to Ccl2−/− mice is associated with reduced laserinduced CNV (Tsutsumi et al., 2003).”
BackgroundResultSarks, S. H., Arnold, J. J., Killingsworth, M. C., & Sarks, J. P. (1999) · British Journal of Ophthalmology · doi:10.1136/bjo.83.3.358 · Cited by 269 · cited 2× · see citing works
“In the earliest stage, they may be visible ophthalmoscopically, when their diameter exceeds 25 µm (Sarks et al., 1999), as semitranslucent punctate dots in retro-illumination.”
BackgroundToll-like receptor polymorphisms and susceptibility to human disease
Misch, E. A., & Hawn, T. R. (2008) · Clinical Science · doi:10.1042/cs20070214 · Cited by 263 · cited 2× · see citing works
“Association with a microbial component triggers upregulation of pro-inflammatory genes such as tissue necrosis factor, interleukin-1b, and interleukin-6, through the NFkB pathway (Misch and Hawn, 2008).”
BackgroundAge-related Macular Degeneration: Clinical Features in a Large Family and Linkage to Chromosome 1q
Klein, M. L. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.8.1082 · Cited by 252 · see citing works
Macrophages inhibit neovascularization in a murine model of age-related macular degeneration
Apte, R. S., Richter, J., Herndon, J., & Ferguson, T. A. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030310 · Cited by 249 · cited 3× · see citing works
“might therefore be secondary to the direct injury to CNV endothelium, rather than the depletion of macrophages (Apte et al., 2006).”
BackgroundInfluentialY402H polymorphism of complement factor H affects binding affinity to C-reactive protein
Laine, M., Jarva, H., Seitsonen, S., Haapasalo, K., Lehtinen, M. J., Lindeman, N., Anderson, D. H., Johnson, P. T., Järvelä, I., Jokiranta, T. S., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3831 · Cited by 246 · cited 1× · see citing works
“This suggests that reduced binding of CRP by CFH might lead to impaired targeting of CFH to cellular debris (Laine et al., 2007; Skerka et al., 2007).”
BackgroundMeta-analysis of genome scans of age-related macular degeneration
Fisher, S. A., Abecasis, G. R., Yashar, B. M., Zareparsi, S., Swaroop, A., Iyengar, S. K., Klein, B. E. K., Klein, R., Lee, K. E., Majewski, J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi230 · Cited by 239 · cited 3× · see citing works
“Many linkage and association studies have indicated that the most replicated signals reside on chromosome 1q25–31 and 10q26 (Fisher et al., 2005; Jakobsdottir et al., 2005; Klein et al., 1998; Majewski et al., 2003).”
BackgroundMethodMullins, R. F., Aptsiauri, N., & Hageman, G. S. (2001) · Eye · doi:10.1038/eye.2001.142 · Cited by 231 · cited 2× · see citing works
“…components and complement regulatory proteins in drusen and nearby RPE of AMD patients (Crabb et al., 2002; Hageman et al., 1999; Johnson et al., 2001; Johnson et al., 2000; Mullins et al., 2001; Nozaki et al., 2006), suggesting a role for complement in AMD pathogenesis (Bora et al., 2008).”
BackgroundComplement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction
Coffey, P. J., Gias, C., McDermott, C. J., Lundh, P., Pickering, M. C., Sethi, C., Bird, A., Fitzke, F. W., Maass, A., Chen, L. L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705079104 · Cited by 231 · cited 1× · see citing works
“At age 2 years, cfh−/− mice exhibited significantly reduced visual acuity and rod response amplitudes on electroretinography as compared with age-matched control mice (Coffey et al., 2007).”
BackgroundJohnson, P. T., Betts, K. E., Radeke, M. J., Hageman, G. S., Anderson, D. H., & Johnson, L. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606234103 · Cited by 223 · cited 2× · see citing works
“CFH dysfunction may lead to excessive inflammation and tissue damage involved in the pathogenesis of AMD (Johnson et al., 2006).”
BackgroundToll-like Receptor 3 and Geographic Atrophy in Age-Related Macular Degeneration
Yang, Z., Stratton, C., Francis, P. J., Kleinman, M. E., Tan, P. L., Gibbs, D., Tong, Z., Chen, H., Constantine, R., Yang, X., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802437 · Cited by 222 · cited 1× · see citing works
“The L412F variant of the TLR3 gene (i.e. a leucine to phenylalanine change at amino acid 412), encoded by the T allele at rs3775291 of the TLR3 gene, has been reported in three case-control cohorts to be protective against dry AMD, possibly through suppression of RPE apoptosis (Yang et al., 2008).”
BackgroundMata, N. L., Tzekov, R. T., Liu, X., Weng, J., Birch, D. G., & Travis, G. H. (2001) · PubMed · Cited by 219 · see citing works
Tuo, J., Smith, B. C., Bojanowski, C. M., Meleth, A. D., Gery, I., Csaky, K. G., Chew, E. Y., & Chan, C.-C. (2004) · The FASEB Journal · doi:10.1096/fj.04-1862fje · Cited by 215 · cited 3× · see citing works
“As described above, the CX3CR1 chemokine receptor found on microglia has been shown to harbor SNPs (T280M and V249I) that have been associated with increased risk of AMD in some reports (Chan et al., 2005; Tuo et al., 2004).”
BackgroundSelf-citationDietary Fat and Fish Intake and Age-Related Maculopathy
Smith, W. T. (2000) · Archives of Ophthalmology · doi:10.1001/archopht.118.3.401 · Cited by 211 · see citing works
Hydrogen Peroxide Causes Significant Mitochondrial DNA Damage in Human RPE Cells
Ballinger, S. W., Houten, B. V., Conklin, C. A., Jin, G., & Godley, B. F. (1999) · Experimental Eye Research · doi:10.1006/exer.1998.0661 · Cited by 209 · cited 1× · see citing works
“Blue light irradiation and treatment with hydrogen peroxide cause long-lasting mtDNA but not nuclear DNA mutations in cultured RPE cells (Ballinger et al., 1999; Godley et al., 2005).”
BackgroundHageman, G. S., Mullins, R. F., Russell, S. R., Johnson, L. V., & Anderson, D. H. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.3.477 · Cited by 206 · cited 2× · see citing works
“A number of studies have illustrated the presence of complement components and complement regulatory proteins in drusen and nearby RPE of AMD patients (Crabb et al., 2002; Hageman et al., 1999; Johnson et al., 2001; Johnson et al., 2000; Mullins et al., 2001; Nozaki et al., 2006), suggesting a role for complement in A…”
BackgroundTuo, J., Bojanowski, C. M., Zhou, M., Shen, D., Ross, R. J., Rosenberg, K. I., Cameron, D. J., Yin, C., Kowalak, J. A., Zhuang, Z., et al. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0051 · Cited by 205 · cited 1× · see citing works
“These mice also exhibited ultrastructural signs of AMD such as accumulation of lipofuscin granules, as well as increased the N-retinylidene–N-retinylethanolamine (A2E) accumulation on biochemical analysis (Chan et al., 2008; Tuo et al., 2007).”
BackgroundSelf-citationAge-related macular degeneration–a genome scan in extended families
Majewski, J., Schultz, D. W., Weleber, R. G., Schain, M. B., Edwards, A. O., Matise, T. C., Acott, T. S., Ott, J., & Klein, M. L. (2003) · The American Journal of Human Genetics · doi:10.1086/377701 · Cited by 201 · cited 3× · see citing works
“A genome-wide scan and genetic linkage analysis of 70 families with AMD suggests that chromosome 10q26 may contain a common AMD gene (Majewski et al., 2003).”
BackgroundAllelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration
Stone, E. M., Webster, A. R., Vandenburgh, K., Streb, L. M., Hockey, R. R., Lotery, A. J., & Sheffield, V. C. (1998) · Nature Genetics · doi:10.1038/3798 · Cited by 197 · cited 1× · see citing works
“Moreover, multiple subsequent studies showed little or no relation of ABCA4 mutations with AMD (Bojanowski et al., 2005; De La Paz et al., 1999; Souied et al., 2000; Stone et al., 1998).”
BackgroundDefective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration
Skerka, C., Lauer, N., Weinberger, A. A. W. A., Keilhauer, C. N., Sühnel, J., Smith, R., Schlötzer–Schrehardt, U., Fritsche, L., Heinen, S., & Hartmann, A. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.012 · Cited by 197 · cited 1× · see citing works
“This suggests that reduced binding of CRP by CFH might lead to impaired targeting of CFH to cellular debris (Laine et al., 2007; Skerka et al., 2007).”
BackgroundWeeks, D. E., Conley, Y. P., Tsai, H.-J., Mah, T. S., Schmidt, S., Postel, E. A., Agarwal, A., Haines, J. L., Pericak-Vance, M. A., Rosenfeld, P. J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/422476 · Cited by 195 · cited 2× · see citing works
“wide linkage studies (Weeks et al., 2004) and supported by a genome-scan meta-analysis (Fisher et al.”
BackgroundMethodZareparsi, S., Buraczynska, M., Branham, K. E. H., Shah, S., Eng, D., Li, M., Pawar, H., Yashar, B. M., Moroi, S. E., Lichter, P. R., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi154 · Cited by 190 · cited 2× · see citing works
“A study by Zareparsi et al reported that the D299G (aspartate to glycine at amino acid 299) TLR4 (encoded in chromosome 9q32–33) polymorphism leads to increased AMD risk (OR = 2.65) (Zareparsi et al., 2005).”
BackgroundInfluentialHaines, J. L., Schnetz-Boutaud, N., Schmidt, S., Scott, W. K., Agarwal, A., Postel, E. A., Olson, L., Kenealy, S. J., Hauser, M., Gilbert, J. R., et al. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0116 · Cited by 189 · cited 1× · see citing works
“Neovascular AMD was found to be associated with the rs2010963 (G634C) VEGF-A SNP in a case-control cohort, and in a family cohort with two intronic VEGF-A SNPs (rs833070 and rs3025030) (Haines et al., 2006).”
BackgroundNordgaard, C. L., Karunadharma, P. P., Feng, X., Olsen, T. W., & Ferrington, D. A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1352 · Cited by 188 · cited 1× · see citing works
“Recently, several studies offered direct evidence of mitochondrial alterations in AMD (Feher et al., 2006; Nordgaard et al., 2006, 2008).”
BackgroundVEGF polymorphisms are associated with neovascular age-related macular degeneration
Churchill, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl238 · Cited by 187 · cited 3× · see citing works
“Another study, which involved 45 patients with neovascular disease, identified a haplotypic association in both the promoter and an intronic region of the VEGF gene (Churchill et al., 2006).”
BackgroundInfluentialMacular function impairment in eyes with early age-related macular degeneration.
Midena, E., Angeli, C. D., Blarzino, M. C., Valenti, M., & Segato, T. (1997) · PubMed · Cited by 180 · see citing works
The AU-Rich Transcriptome: More Than Interferons and Cytokines, and Its Role in Disease
Khabar, K. S. A. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.1 · Cited by 174 · cited 1× · see citing works
“The insertion introduces a 54-bp AU-rich element, known for its properties to control mRNA decay in many transcripts that encode a wide variety of proteins involved in transient biological processes (Barreau et al., 2005; Garneau et al., 2007; Khabar, 2005).”
BackgroundTransforming growth factor-β: innately bipolar
Wahl, S. M. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.11.008 · Cited by 174 · cited 1× · see citing works
“TGFβ also is a potent inhibitor for immune response (Lehner, 2008; Wahl, 2007).”
BackgroundKlein, M. L., Francis, P. J., Rosner, B., Reynolds, R., Hamon, S. C., Schultz, D. W., Ott, J., & Seddon, J. M. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.01.036 · Cited by 172 · cited 3× · see citing works
“Complement system While AMD is a highly complex disease with numerous intersecting etiological factors, recent studies have generated significant interest in the inflammatory underpinnings of AMD pathogenesis (Klein et al., 2008b).”
BackgroundEnnis, S., Jomary, C., Mullins, R., Cree, A., Chen, X., MacLeod, A., Jones, S., Collins, A., Stone, E., & Lotery, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61348-3 · Cited by 171 · cited 1× · see citing works
“Moreover, the SNP variant rs2511989 located in the SERPING1 gene encoding the complement component 1 (C1) inhibitor was recently reported to occur less frequently in AMD cases than in control subjects (Ennis et al., 2008).”
BackgroundAzarian, S. M., & Travis, G. H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00517-6 · Cited by 170 · see citing works
Russell, S. R., Mullins, R. F., Schneider, B. L., & Hageman, G. S. (2000) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00345-1 · Cited by 170 · cited 1× · see citing works
“The molecular and cellular constituents of drusen have been analyzed extensively (Anderson et al., 2004; Crabb et al., 2002; Hageman et al., 2001; Johnson et al., 2000; Mullins et al., 2000; Russell et al., 2000).”
BackgroundImmunopathological aspects of age-related macular degeneration
Patel, M. M., & Chan, C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 163 · cited 2× · see citing works
“Moreover, several studies have demonstrated that animal models with complement knockdown, either genetically or with pharmacological agents such as anti-complement antibodies, exhibit decreased CNV after laser injury, a commonly employed model for AMD-associated CNV in humans (Patel and Chan, 2008).”
BackgroundSelf-citationGranulomatous reaction to Bruch's membrane in age-related macular degeneration
Dastgheib, K. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090180111045 · Cited by 162 · cited 2× · see citing works
“…the macrophages, have been histologically demonstrated near AMD lesions, including in areas of Bruch membrane breakdown, RPE atrophy, and choroidal neovascularization (Coleman et al., 2008; Dastgheib and Green, 1994; Green, 1999; Grossniklaus et al., 2002; Lopez et al., 1993; Penfold et al., 2001).”
BackgroundDecanini, A., Nordgaard, C. L., Feng, X., Ferrington, D. A., & Olsen, T. W. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.12.006 · Cited by 157 · cited 2× · see citing works
“, 2004) and higher levels of antioxidant enzymes (Decanini et al., 2007; Frank et al., 1999) compared with non-AMD eyes, which indicate that oxidative stress plays an important role in AMD.”
BackgroundConley, Y. P., Jakobsdottir, J., Mah, T., Weeks, D. E., Klein, R., Kuller, L., Ferrell, R. E., & Gorin, M. B. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl396 · Cited by 157 · see citing works
Foxman, E. F., Zhang, M.-F., Hurst, S., Muchamuel, T., Shen, D., Wawrousek, E., Chan, C.-C., & Gery, I. (2002) · Journal of Immunology · doi:10.4049/jimmunol.168.5.2483 · Cited by 155 · cited 1× · see citing works
“Both CX3CR1 and CX3CL1 are rich in the retina and brain (Combadiere et al., 1998; Foxman et al., 2002).”
BackgroundSelf-citationA pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy
Schmidt, S., Klaver, C. C. W., Saunders, A. M., Postel, E. A., De La Paz, M. A., Agarwal, A., Small, K. W., Udar, N., Ong, J. M., Chalukya, M. V., et al. (2002) · Ophthalmic Genetics · doi:10.1076/opge.23.4.209.13883 · Cited by 149 · see citing works
Nordgaard, C. L., Berg, K. M., Kapphahn, R. J., Reilly, C., Feng, X., Olsen, T. W., & Ferrington, D. A. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0976 · Cited by 149 · cited 1× · see citing works
“Recently, several studies offered direct evidence of mitochondrial alterations in AMD (Feher et al., 2006; Nordgaard et al., 2006, 2008).”
BackgroundZareparsi, S. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1253 · Cited by 145 · cited 2× · see citing works
“Several studies later confirmed a role for ApoE SNP in AMD (Baird et al., 2006; Jun et al., 2005; Kovacs et al., 2007; Schmidt et al., 2002; Souied et al., 1998; Zareparsi et al., 2004), while others found no effect (Kaur et al.”
BackgroundKaiser, P. K. (2006) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.05.061 · Cited by 136 · cited 1× · see citing works
“Pegaptanib (macugen), an oligonucleotide aptamer that targets the VEGF165 isoform, and ranibizumab (Lucentis) and bevacizumab (Avastin), both monoclonal antibodies against VEGF-A, are currently employed in AMD therapy (Ferrara et al., 2006; Kaiser, 2006).”
MethodReceptor for advanced glycation end products and age-related macular degeneration
Howes, K. A., Liu, Y., Dunaief, J. L., Milam, A., Frederick, J. M., Marks, A., & Baehr, W. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0404 · Cited by 131 · cited 1× · see citing works
“and lipids (Crabb et al., 2002; Howes et al., 2004) and higher levels of antioxidant enzymes (Decanini et al.”
BackgroundAge-related macular degeneration and the immune response: implications for therapy
Nussenblatt, R. B., & Ferris, F. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2007.06.025 · Cited by 130 · see citing works
Chen, H., Liu, B., Lukas, T. J., & Neufeld, A. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002339 · Cited by 129 · cited 1× · see citing works
“A recent study of age-related changes demonstrates recruitment of leukocytes and activation of the complement cascade in mouse RPE and choroid (Chen et al., 2008).”
BackgroundCirculating anti-retinal antibodies as immune markers in age-related macular degeneration
Patel, N., Ohbayashi, M., Nugent, A. K., Ramchand, K., Toda, M., Chau, K., Bunce, C., Webster, A., Bird, A. C., Ono, S. J., et al. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02173.x · Cited by 125 · cited 2× · see citing works
“Given prior reports of increased anti-retinal antibodies in patients with AMD (Cherepanoff et al., 2006; Joachim et al., 2007; Patel et al., 2005), we also investigated whether Prog Retin Eye Res.”
BackgroundComplement factor H polymorphisms in Japanese population with age-related macular degeneration.
Okamoto, H., Umeda, S., Obazawa, M., MINAMI, M., Noda, T., Mizota, A., Honda, M., Tanaka, M., Koyama, R., Takagi, I., et al. (2006) · PubMed · Cited by 120 · see citing works
Frank, R. N., Amin, R., & Puklin, J. E. (1999) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)00032-x · Cited by 118 · cited 2× · see citing works
“, 2004) and higher levels of antioxidant enzymes (Decanini et al., 2007; Frank et al., 1999) compared with non-AMD eyes, which indicate that oxidative stress plays an important role in AMD.”
BackgroundTuo, J., Ning, B., Bojanowski, C. M., Lin, Z.-N., Ross, R. J., Reed, G. F., Shen, D., Jiao, X., Zhou, M., Chew, E. Y., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603485103 · Cited by 114 · cited 3× · see citing works
“Enhanced ERCC6 expression is observed in lymphocytes from healthy donors bearing ERCC6 C6530G alleles (Tuo et al., 2006).”
BackgroundSelf-citationCameron, D. J., Yang, Z., Gibbs, D., Chen, H., Kaminoh, Y., Jorgensen, A., Zeng, J., Luo, L., Brinton, E., Brinton, G., et al. (2007) · Cell Cycle · doi:10.4161/cc.6.9.4157 · Cited by 114 · cited 6× · see citing works
“…M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript HtrA1 mRNA and/or protein in the drusen and CNV components in AMD patients carrying the AA risk genotype has been reported in several studies (Cameron et al., 2007; Chan et al., 2007; Tuo et al., 2008; Yang et al., 2006) (Fig.”
BackgroundResultInfluentialAssociation of complement factor H polymorphisms with exudative age-related macular degeneration.
Chen, L. J., Liu, D. T. L., Tam, P. O. S., Chan, W. M., Liu, K., Chong, K. K. L., Lam, D. S. C., & Pang, C. P. (2006) · PubMed · Cited by 111 · see citing works
Regulated expression of apolipoprotein E by human retinal pigment epithelial cells
Ishida, B. Y., Bailey, K. R., Duncan, K. G., Chalkley, R. J., Burlingame, A. L., Kane, J. P., & Schwartz, D. M. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m300306-jlr200 · Cited by 111 · cited 1× · see citing works
“These findings suggest a possible role for ApoE in AMD pathology via retinal lipid trafficking (Ishida et al., 2004).”
BackgroundOverview of progress in the epidemiology of age-related macular degeneration
Klein, R. (2007) · Ophthalmic Epidemiology · doi:10.1080/09286580701344381 · Cited by 110 · cited 1× · see citing works
“The relationship between smoking and AMD has been investigated in numerous cross-sectional studies, cohort studies, and case-control studies (Klein, 2007).”
BackgroundMouse models of age-related macular degeneration
Elizabeth Rakoczy, P., Yu, M. J. T., Nusinowitz, S., Chang, B., & Heckenlively, J. R. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2005.10.012 · Cited by 107 · cited 1× · see citing works
“Most of the retinal degeneration genes found first in mouse have been linked to a corresponding human retinal disease, and thus we know that identifying disease-related genes in mice is both relevant and important (Rakoczy et al., 2006).”
BackgroundInflammation, Complement Factor H, and Age-Related Macular Degeneration
Klein, R., Knudtson, M. D., Klein, B. E. K., Wong, T. Y., Cotch, M. F., Liu, K., Cheng, C. Y., Burke, G. L., Saad, M. F., Jacobs, D. R., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.03.021 · Cited by 106 · cited 3× · see citing works
“Complement system While AMD is a highly complex disease with numerous intersecting etiological factors, recent studies have generated significant interest in the inflammatory underpinnings of AMD pathogenesis (Klein et al., 2008b).”
BackgroundFamily history and age‐related maculopathy: The Blue Mountains Eye Study
Smith, W. H., & Mitchell, P. L. R. (1998) · Australian and New Zealand Journal of Ophthalmology · doi:10.1111/j.1442-9071.1998.tb01311.x · Cited by 106 · cited 1× · see citing works
“Several family studies have shown that patients with a family history of AMD are at increased risk (Seddon et al., 2007; Smith and Mitchell, 1998).”
BackgroundAnalysis of the Stargardt disease gene (ABCR) in age-related macular degeneration
De La Paz, M. A., Guy, V. K., Abou-Donia, S., Heinis, R., Bracken, B., Vance, J. M., Gilbert, J. R., Gass, J. D. M., Haines, J. L., & Pericak-Vance, M. A. (1999) · Ophthalmology · doi:10.1016/s0161-6420(99)90449-9 · Cited by 106 · cited 1× · see citing works
“Moreover, multiple subsequent studies showed little or no relation of ABCA4 mutations with AMD (Bojanowski et al., 2005; De La Paz et al., 1999; Souied et al., 2000; Stone et al., 1998).”
BackgroundApolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)
Baird, P. N., Richardson, A. J., Robman, L. D., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2006) · Human Mutation · doi:10.1002/humu.20288 · Cited by 105 · cited 2× · see citing works
“Several studies later confirmed a role for ApoE SNP in AMD (Baird et al., 2006; Jun et al., 2005; Kovacs et al., 2007; Schmidt et al., 2002; Souied et al., 1998; Zareparsi et al., 2004), while others found no effect (Kaur et al.”
BackgroundAPOE genotype, ethnicity, and the risk of cerebral hemorrhage
Tzourio, C., Arima, H., Harrap, S. B., Anderson, C. S., Godin, O., Woodward, M., Neal, B. C., Bousser, M., Chalmers, J. P., Cambien, F., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000308819.43401.87 · Cited by 104 · cited 1× · see citing works
“ApoE polymorphisms have already been linked to several neurodegenerative diseases, including Alzheimer disease, and prion diseases (Krasnianski et al., 2008; Tzourio et al., 2008).”
BackgroundDeAngelis, M. M., Ji, F., Adams, S., Morrison, M. A., Harring, A. J., Sweeney, M. O., Capone, A., Miller, J. W., Dryja, T. P., Ott, J., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.10.032 · Cited by 104 · cited 4× · see citing works
“0 in heterozygous and homozygous individuals (Caucasians, Chinese and Japanese), respectively (Cameron et al., 2007; Deangelis et al., 2008; Dewan et al., 2006; Mori et al., 2007; Tam et al., 2008; Yang et al., 2006).”
BackgroundResultInfluentialMacular function impairment in eyes with early age-related macular degeneration
Degli, C., Blarzino, M., Valenti, M., Segato, T., & Mideno, E. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)71163-8 · Cited by 104 · cited 1× · see citing works
“In addition to photoreceptor degeneration and lipofuscin accumulation, this model also demonstrates decreased recovery of rod cell sensitivity after light exposure (Midena et al., 1997; Weng et al., 1999).”
BackgroundHtrA1-dependent proteolysis of TGF-β controls both neuronal maturation and developmental survival
Launay, S., Maubert, E., Lebeurrier, N., Tennstaedt, A., Campioni, M., Docagne, F., Gabriel, C., Dauphinot, L., Potier, M., Ehrmann, M., et al. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.82 · Cited by 103 · cited 5× · see citing works
“It is also possible that ARMS2 and its pathway may be linked to mitochondrial oxidative stress, while HtrA1 and its pathway may be involved in the regulation of cell survival via chaperon/proteases (Clausen et al., 2002), and the inhibition of immune response via TGF-β (Launay et al., 2008).”
BackgroundInfluentialRetina-derived microglial cells induce photoreceptor cell death in vitro
Roque, R. S., Rosales, A. A., Jingjing, L., Agarwal, N., & Al-Ubaidi, M. R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01625-x · Cited by 101 · cited 2× · see citing works
“This is supported by at least one study demonstrating photoreceptor cell injury after administration of activated microglia to healthy photoreceptors (Roque et al., 1999).”
BackgroundLafaut, B. A. (2000) · British Journal of Ophthalmology · doi:10.1136/bjo.84.11.1269 · Cited by 99 · cited 1× · see citing works
“RAP refers to new vessel development extending outward into the subretinal space from the neurosensory retina, sometimes anastomosing with the choroid-derived vessels (Lafaut et al., 2000).”
BackgroundHistopathology of age-related macular degeneration
Kang, S. J., & Grossniklaus, H. E. (2012) · CRC Press eBooks · doi:10.1201/b14548-2 · Cited by 99 · see citing works
<i>Ccl2/Cx3cr1-</i>Deficient Mice: An Animal Model for Age-Related Macular Degeneration
Chan, C.-C., Ross, R. J., Shen, D., Ding, X., Majumdar, Z., Bojanowski, C. M., Zhou, M., Salem, Jr., Bonner, R., & Tuo, J. (2008) · Ophthalmic Research · doi:10.1159/000119862 · Cited by 98 · cited 1× · see citing works
“These mice also exhibited ultrastructural signs of AMD such as accumulation of lipofuscin granules, as well as increased the N-retinylidene–N-retinylethanolamine (A2E) accumulation on biochemical analysis (Chan et al., 2008; Tuo et al., 2007).”
BackgroundSelf-citationPenfold, P. L., Wong, J. G., Gyory, J., & Billson, F. A. (2001) · Clinical & Experimental Ophthalmology · doi:10.1046/j.1442-9071.2001.00407.x · Cited by 97 · cited 4× · see citing works
“Macrophages in CNV—Several groups have demonstrated the presence of macrophages at neovascular membranes in wet AMD (Dastgheib and Green, 1994; Grossniklaus et al., 2002; Penfold et al., 2001).”
BackgroundInfluentialEffects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice.
Ong, J. M., Zorapapel, N. C., Rich, K. A., Wagstaff, R. E., Lambert, R. W., Rosenberg, S., Moghaddas, F., Pirouzmanesh, A., Aoki, A. M., & Kenney, M. C. (2001) · PubMed · Cited by 92 · see citing works
Mitochondrial abnormalities in ageing macular photoreceptors
Barron, M. J., Johnson, M. A., Andrews, R. M., Clarke, M., Griffiths, P. G., Bristow, E., He, L., Durham, S., & Turnbull, D. M. (2001) · PubMed · doi:10.25405/ncl.34603167 · Cited by 90 · see citing works
Complement factor H binds to denatured rather than to native pentameric C-reactive protein
Hakobyan, S., Harris, C. L., van den Berg, C. W., Fernandez-Alonso, M. C., de Jorge, E. G., de Cordoba, S. R., Rivas, G., Mangione, P., Pepys, M. B., & Morgan, B. P. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803648200 · Cited by 90 · cited 13× · see citing works
“It is also possible that persistent chronic inflammation that is a byproduct of attenuated complement-inhibitory activity may occur in those individuals with the risk-conferring CFH SNP Y402H and that this proinflammatory state, rather than impaired binding by CFH, leads to CRP accumulation in AMD retina.”
BackgroundInfluentialBaird, P. N., Robman, L. D., Richardson, A. J., Dimitrov, P. N., Tikellis, G., McCarty, C. A., & Guymer, R. H. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn018 · Cited by 90 · see citing works
Dendritic Cells in Chronic Obstructive Pulmonary Disease
Tsoumakidou, M., Demedts, I., Brusselle, G., & Jeffery, P. K. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200711-1727pp · Cited by 87 · cited 1× · see citing works
“Smoking also has an effect on the immune system (Tsoumakidou et al., 2008).”
BackgroundVascular Endothelial Growth Factor Gene Polymorphisms in Age-related Macular Degeneration
Lin, J.-M., Wan, L., Tsai, Y., Lin, H., Tsai, Y., Lee, C.-C., Tsai, C., Tseng, S.-H., & Tsai, F. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.01.027 · Cited by 87 · cited 2× · see citing works
“genotyped five VEGF-A polymorphisms: C2578A, T460C, C405G, C674T, and C936T in a Chinese population study and found that only the VEGF C936T SNP was significantly increased in wet AMD (Lin et al., 2008).”
BackgroundAlsenz, J., Schulz, T. F., Lambris, J. D., Sim, R. B., & Dierich, M. P. (1985) · Biochemical Journal · doi:10.1042/bj2320841 · Cited by 87 · cited 1× · see citing works
“The C3b–Bb complex is a key component of the alternative pathway, and CFH inhibits the alternative pathway by promoting Factor I-mediated inactivation of C3b or by displacing Factor Bb from the C3bBb complex (Alsenz et al., 1985).”
BackgroundKalayoglu, M. V., Bula, D., Arroyo, J., Gragoudas, E. S., D’Amico, D., & Miller, J. W. (2005) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-1169-y · Cited by 86 · cited 2× · see citing works
“Moreover, C. pneumoniae has been found in AMD neovascular membranes (Kalayoglu et al., 2005).”
BackgroundKindzelskii, A. L., Elner, V. M., Elner, S. G., Yang, D., Hughes, B. A., & Petty, H. R. (2004) · The Journal of General Physiology · doi:10.1085/jgp.200409062 · Cited by 85 · cited 1× · see citing works
“Moreover, TLR4 has also been implicated in photoreceptor outer segment handling and phagocytosis by RPE cells (Kindzelskii et al., 2004).”
BackgroundKaur, I., Hussain, A., Hussain, N., Das, T., Pathangay, A., Mathai, A., Hussain, A., Nutheti, R., Nirmalan, P. K., & Chakrabarti, S. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1430 · Cited by 84 · cited 4× · see citing works
“A recent population-based cohort study in Australia (Tan et al., 2008) demonstrated that high dietary lutein and zeaxanthin intake reduced the risk of long-term incident AMD and that high beta-carotene intake was associated with an increased risk of AMD.”
BackgroundMethodInfluentialHTRA1 Variants in Exudative Age-Related Macular Degeneration and Interactions with Smoking and CFH
Tam, P. O. S., Ng, T. K., Liu, D. T. L., Chan, W. M., Chiang, S. W. Y., Chen, L. J., DeWan, A. T., Hoh, J. J., Lam, D. S. C., & Pang, C. P. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1520 · Cited by 84 · cited 4× · see citing works
“…increase in population attributable risk (about 5.5-fold increase) by the joint effect of smoking and the HtaA1 risk allele, indicating that smokers homozygous for the risk allele had a substantially higher risk of developing wet AMD than non-smokers with the risk allele (Tam et al., 2008).”
BackgroundInfluentialBrantley, M. A., Edelstein, S. L., King, J. M., Plotzke, M. R., Apte, R. S., Kymes, S. M., & Shiels, A. (2008) · Eye · doi:10.1038/eye.2008.28 · Cited by 84 · see citing works
Toll-like receptor polymorphisms and age-related macular degeneration
Edwards, A. O., Chen, D., Fridley, B. L., James, K. M., Wu, Y., Abecasis, G., Swaroop, A., Othman, M., Branham, K., Iyengar, S. K., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1378 · Cited by 84 · cited 4× · see citing works
“Further analyses of more cohorts or reanalyses of the above cohorts with absolutely normal controls could help to clarify the association of TLR with AMD (Edwards et al., 2008; Kaiser, 2008).”
BackgroundMethodResultInfluentialWell-defined Subfoveal Choroidal Neovascular Membranes in Age-related Macular Degeneration
Lopez, P. F., Lambert, H. M., Grossniklaus, H. E., & Sternberg, P. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31657-x · Cited by 81 · cited 2× · see citing works
“…the macrophages, have been histologically demonstrated near AMD lesions, including in areas of Bruch membrane breakdown, RPE atrophy, and choroidal neovascularization (Coleman et al., 2008; Dastgheib and Green, 1994; Green, 1999; Grossniklaus et al., 2002; Lopez et al., 1993; Penfold et al., 2001).”
Background(2005) · PubMed · doi:10.14670/hh-20.857 · Cited by 81 · cited 3× · see citing works
“We have also compared expression of CX3CR1 mRNA and protein in AMD macular cells obtained from archived paraffin-embedded tissue sections (Chan et al., 2005).”
BackgroundSelf-citationInterleukin-8 promoter polymorphism -251A/T is a risk factor for age-related macular degeneration
Goverdhan, S. V., Ennis, S., Hannan, S. R., Madhusudhana, K. C., Cree, A. J., Luff, A. J., & Lotery, A. J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.123190 · Cited by 79 · cited 3× · see citing works
“The interleukin-8 (IL8) A251T genetic polymorphism located in chromosome 4q13–21 is reported to be associated with AMD, with the homozygous AA genotype (A allele) as the “at risk” factor (Goverdhan et al., 2008).”
BackgroundInfluentialRinne, M. L., Caldwell, D. B., & Kelley, M. R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.955.3.8 · Cited by 79 · cited 1× · see citing works
“Overexpression of a single element in an enzyme complex can adversely impact complex functionality (Rinne et al., 2004).”
BackgroundExposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration
Robman, L., Mahdi, O., McCarty, C., Dimitrov, P., Tikellis, G., McNeil, J., Byrne, G., Taylor, H., & Guymer, R. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi130 · Cited by 77 · cited 2× · see citing works
“pneumoniae antibodies, and these antibodies have been linked to increased risk of AMD progression (Robman et al., 2005).”
BackgroundLehner, T. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02780.x · Cited by 76 · cited 1× · see citing works
“TGFβ also is a potent inhibitor for immune response (Lehner, 2008; Wahl, 2007).”
BackgroundSchultz, D. W. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.5.679 · Cited by 76 · cited 4× · see citing works
“A recent population-based cohort study in Australia (Tan et al., 2008) demonstrated that high dietary lutein and zeaxanthin intake reduced the risk of long-term incident AMD and that high beta-carotene intake was associated with an increased risk of AMD.”
BackgroundMethodInfluentialRoss, R. J., Bojanowski, C. M., Wang, J. J., Chew, E. Y., Rochtchina, E., Ferris, F. L., Mitchell, P., Chan, C.-C., & Tuo, J. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.06-0999 · Cited by 75 · cited 4× · see citing works
“ARMS2 SNP and AMD—The association of ARMS2 gene with AMD, especially advanced AMD, susceptibility has now been replicated in numbers of independent studies (Conley et al., 2006; Rivera et al., 2005; Ross et al., 2007; Schmidt et al., 2006; Seddon et al., 2007; Kanda et al., 2007).”
BackgroundResultInfluentialSelf-citationCombadière, C., Gao, J., Tiffany, H. L., & Murphy, P. M. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9849 · Cited by 70 · cited 1× · see citing works
“Both CX3CR1 and CX3CL1 are rich in the retina and brain (Combadiere et al., 1998; Foxman et al., 2002).”
BackgroundThe LOC387715 Polymorphism, Inflammatory Markers, Smoking, and Age-Related Macular Degeneration
Wang, J. J., Ross, R. J., Tuo, J., Burlutsky, G., Tan, A. G., Chan, C.-C., Favaloro, E. J., Williams, A., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.05.038 · Cited by 69 · cited 3× · see citing works
“Our data, including a population-based study (Wang et al., 2008), and data by Jakobsdottir and colleagues (Jakobsdottir et al., 2005) have both shown that the frequency of the ARMS2 risk allele is higher in patients with advanced AMD than in those with early or intermediate AMD.”
BackgroundMethodResultSelf-citationInterleukin gene polymorphisms in age-related macular degeneration
Tsai, Y.-Y., Lin, J.-M., Wan, L., Lin, H.-J., Tsai, Y., Lee, C.-C., Tsai, C.-H., Tsai, F.-J., & Tseng, S.-H. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0125 · Cited by 69 · cited 1× · see citing works
“Taiwan Chinese carriers of the IL8 C781T variant, independent to the CFH Y402H variant, have also been shown to be at increased risk of developing wet AMD (Tsai et al., 2008).”
BackgroundThe role of complement in ocular pathology
Bora, N. S., Jha, P., & Bora, P. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0110-y · Cited by 69 · cited 2× · see citing works
“…components and complement regulatory proteins in drusen and nearby RPE of AMD patients (Crabb et al., 2002; Hageman et al., 1999; Johnson et al., 2001; Johnson et al., 2000; Mullins et al., 2001; Nozaki et al., 2006), suggesting a role for complement in AMD pathogenesis (Bora et al., 2008).”
BackgroundShanmugaratnam, J., Berg, E., Kimerer, L., Johnson, R. J., Amaratunga, A., Schreiber, B. M., & Fine, R. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00176-9 · Cited by 68 · cited 4× · see citing works
“…E (ApoE) Apo-E is a structural component of plasma chylomicrons, very low-density lipoproteins (VLDL), and a subclass of high-density lipoproteins (HDL), and is synthesized in many tissues including the spleen, kidneys, lungs, adrenal glands, liver, and brain (Shanmugaratnam et al., 1997).”
BackgroundInfluentialABCR gene analysis in familial exudative age-related macular degeneration.
Souied, E. H., Ducroq, D., Rozet, J., Gerber, S., Perrault, I., Münnich, A., COSCAS, G. J., Soubrane, G., & Kaplan, J. (2000) · PubMed · Cited by 66 · see citing works
Biochemical Analysis of a Common Human Polymorphism Associated with Age-Related Macular Degeneration
Yu, J., Wiita, P., Kawaguchi, R., Honda, J., Jorgensen, A. J., Zhang, K., Fischetti, V. A., & Sun, H. (2007) · Biochemistry · doi:10.1021/bi700459a · Cited by 64 · cited 15× · see citing works
“It is also possible that persistent chronic inflammation that is a byproduct of attenuated complement-inhibitory activity may occur in those individuals with the risk-conferring CFH SNP Y402H and that this proinflammatory state, rather than impaired binding by CFH, leads to CRP accumulation in AMD retina.”
BackgroundInfluentialTuo, J., Ross, R. J., Reed, G. F., Yan, Q., Wang, J. J., Bojanowski, C. M., Chew, E. Y., Feng, X., Olsen, T. W., Ferris, F. L., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.05.021 · Cited by 63 · cited 4× · see citing works
“…M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript HtrA1 mRNA and/or protein in the drusen and CNV components in AMD patients carrying the AA risk genotype has been reported in several studies (Cameron et al., 2007; Chan et al., 2007; Tuo et al., 2008; Yang et al., 2006) (Fig.”
BackgroundResultInfluentialSelf-citationMori, K., Horie‐Inoue, K., Kohda, M., Kawasaki, I., Gehlbach, P. L., Awata, T., Yoneya, S., Okazaki, Y., & Inoue, S. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0162-1 · Cited by 63 · cited 4× · see citing works
“0 in heterozygous and homozygous individuals (Caucasians, Chinese and Japanese), respectively (Cameron et al., 2007; Deangelis et al., 2008; Dewan et al., 2006; Mori et al., 2007; Tam et al., 2008; Yang et al., 2006).”
BackgroundInfluentialExpression of transforming growth factor-ß mRNA in experimental choroidal neovascularization
Ogata, N., Yamamoto, C., Miyashiro, M., Yamada, H., Matsushima, M., & Uyama, M. (1997) · Current Eye Research · doi:10.1076/ceyr.16.1.9.5121 · Cited by 62 · cited 2× · see citing works
“, 2006), or by binding to transforming growth factor (TGF)-β, an angiogenic factor whose expression has been geographically and temporally linked to CNV (Ogata et al., 1997; Oka et al., 2004).”
BackgroundBojanowski, C. M., Shen, D., Chew, E. Y., Ning, B., Csaky, K. G., Green, W. R., Chan, C., & Tuo, J. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20233 · Cited by 62 · see citing works
Self-citationRoss, R. J., Zhou, M., Shen, D., Fariss, R. N., Ding, X., Bojanowski, C. M., Tuo, J., & Chan, C.-C. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.01.014 · Cited by 60 · cited 3× · see citing works
“Macrophage and microglial accumulation was also increased relative to wild-type in Ccl2−/−/Cx3cr1−/− mice, as well as in Cx3cr1−/− mice, though to a lesser degree (Ross et al., 2008).”
BackgroundInfluentialSelf-citationDespriet, D. D. G., Bergen, A. A. B., Merriam, J. E., Zernant, J., Barile, G. R., Smith, R. T., Barbazetto, I. A., van Soest, S., Bakker, A., de Jong, P. T. V. M., et al. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0656 · Cited by 60 · cited 1× · see citing works
“Subsequent studies, for example by Despriet and Edwards, however, demonstrated no significant association of the D299G TLR4 SNP with AMD risk (Despriet et al., 2008; Edwards et al., 2008).”
ResultJoachim, S. C., Bruns, K., Lackner, K. J., Pfeiffer, N., & Grus, F. H. (2007) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0429-9 · Cited by 60 · cited 2× · see citing works
“Given prior reports of increased anti-retinal antibodies in patients with AMD (Cherepanoff et al., 2006; Joachim et al., 2007; Patel et al., 2005), we also investigated whether our mouse model possesses such antibodies.”
BackgroundHuman HtrA1 in the archived eyes with age-related macular degeneration.
Chan, C., Shen, D., Zhou, M., Ross, R. J., Ding, X., Zhang, K., Green, W. R., & Tuo, J. (2007) · Europe PMC (PubMed Central) · Cited by 59 · see citing works
Self-citationEvidence for association between multiple complement pathway genes and AMD
Dinu, V., Miller, P. L., & Zhao, H. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20204 · Cited by 58 · cited 3× · see citing works
“These SNPs have been reported to be major genetic factors for developing AMD in Caucasians (Edwards et al., 2005; Hageman et al., 2005; Haines et al., 2005; Klein et al., 2005; Tuo et al., 2006).”
BackgroundInfluentialJoint effects of smoking history and APOE genotypes in age-related macular degeneration.
Schmidt, S., Haines, J. L., Postel, E. A., Agarwal, A., Kwan, S. Y., Gilbert, J. R., Pericak‐Vance, M. A., & Scott, W. K. (2005) · PubMed · Cited by 55 · see citing works
Molecular analysis of C3 allotypes in patients with nephritic factor
Finn, J. E., & Mathieson, P. W. (1993) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05917.x · Cited by 52 · cited 2× · see citing works
“glomerular basement membrane of the kidney (Finn and Mathieson, 1993; Pickering et al., 2002).”
BackgroundRichardson, A. J., Islam, A. F. M., Guymer, R. H., Cain, M. S., & Baird, P. N. (2007) · PubMed · Cited by 47 · see citing works
Cherepanoff, S., Mitchell, P., Wang, J. J., & Gillies, M. C. (2006) · Clinical & Experimental Ophthalmology · doi:10.1111/j.1442-9071.2006.01281.x · Cited by 47 · cited 2× · see citing works
“Given prior reports of increased anti-retinal antibodies in patients with AMD (Cherepanoff et al., 2006; Joachim et al., 2007; Patel et al., 2005), we also investigated whether Prog Retin Eye Res.”
BackgroundMontes, T., Goicoechea de Jorge, E., Ramos, R., Gomà, M., Pujol, O., Sánchez-Corral, P., & Rodríguez de Córdoba, S. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.01.027 · Cited by 47 · cited 1× · see citing works
“C3F has in fact been associated with several diseases, including membranoproliferative glomerulonephritis type II (Montes et al., 2008).”
BackgroundApolipoprotein E Gene and Early Age-Related MaculopathyThe Atherosclerosis Risk in Communities Study
Wong, T. Y., SHANKAR, A., Klein, R., Bray, M. S., Couper, D. J., KLEIN, B., SHARRETT, A., & Folsom, A. R. (2006) · Ophthalmology · doi:10.1016/j.ophtha.2005.10.048 · Cited by 38 · cited 2× · see citing works
“However, a large, population-based, cross-sectional study (n = 10,139) using participants from the Atherosclerosis Risk in Communities Study found no association between AMD and any of the ApoE alleles in Australia (Kaur et al., 2006; Schmidt et al., 2005; Schultz et al., 2003; Wong et al., 2006).”
BackgroundMethodShuler, R. K., Schmidt, S., Gallins, P. J., Hauser, M. A., Scott, W. K., Caldwell, J., Agarwal, A., Haines, J. L., Pericak‐Vance, M. A., & Postel, E. A. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.06.021 · Cited by 37 · see citing works
Lee, S., Kim, J. H., Kim, J. H., Chung, M. J., Wen, Q., Chung, H., Kim, K. W., & Yu, Y. S. (2007) · PubMed · Cited by 33 · see citing works
Optical coherence tomography (OCT) angiomatous prolifieration (RAP) in retinal.
Brancato, R., Introini, U., Pierro, L., Setaccioli, M., Forti, M., Bolognesi, G., & Tremolada, G. (2002) · PubMed · Cited by 33 · see citing works
Optical Coherence Tomography (OCT) in Retinal Angiomatous Proliferation (RAP)
Brancato, R., Introini, U., Pierro, L., Setaccioli, M., Forti, M., Bolognesi, G., & Tremolada, G. (2002) · European Journal of Ophthalmology · doi:10.1177/112067210201200604 · Cited by 33 · cited 1× · see citing works
“…mainly from the retinal circulation in a process that has been called retinal angiomatous proliferations (RAP), also called deep retinal vascular anomalous complex or retinochoroidal anastomosis (Brancato et al., 2002;Donati et al., 2006;Ghazi, 2002;Hunter et al., 2004;Yannuzzi et al., 2001).”
BackgroundOptical coherence tomography (OCT) in retinal angiomatous proliferation (RAP).
Brancato, R., Introini, U., Pierro, L., et al. (2002) · PubMed · doi:10.5301/ejo.2008.2283 · Cited by 31 · see citing works
Association of complement factor H polymorphisms with exudative age-related macular degeneration
Chen, L. J., Liu, D. T. L., Tam, P. O. S., Chan, W., Liu, K., Chong, K. K. L., Lam, D. S. C., & Pang, C. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.12.019 · Cited by 31 · cited 1× · see citing works
“In the Chinese and Japanese populations, only three of these CFH SNPs–at rs1329428, rs800292 (I62V), and rs3753394, but not at rs1061170 (Y402H)–were associated with risk of exudative AMD (Chen et al., 2006; Okamoto et al., 2006).”
Background
Flagged first, then by citations
8 of the 224 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- de Jong, 2007, Polymorphisms in the Vascular Endothelial Growth Factor Gene and Risk of Aging Macula Disorder: The Rotterdam Study, Invest. Ophthalmol. Vis. Sci., 48
- Green, 1996, Retina: growth and aging, Vol. 2, 676
- Hutchison, 1875, Symmetrical central choroidoretinal disease occurring in senile persons, R. Lond. Ophthal. Hosp. Rep, 8, 231
Cited by
Sorted by citations
Age-related macular degeneration
Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G., & Wong, T. Y. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60282-7 · Cited by 1,764 · see citing works
The dynamic nature of Bruch's membrane
Booij, J. C., Baas, D. C., Beisekeeva, J., Gorgels, T. G. M. F., & Bergen, A. A. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.08.003 · Cited by 581 · see citing works
“Bruch’s membrane and AMD pathology Oxidative stress in the RPE and its effects on BM Multiple studies in man, AMD animal models and (RPE) cell lines point toward an important role of oxidative stress in the development of AMD[119].”
InfluentialBernstein, P. S., Li, B., Vachali, P. P., Gorusupudi, A., Shyam, R., Henriksen, B. S., & Nolan, J. M. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.10.003 · Cited by 558 · see citing works
“chromosome 10, along withmyriad other minor genetic risk factors identified through genome-wide association studies (GWAS) (Ding et al., 2009; Kanda et al., 2007; Klein et al., 2005; Montezuma et al., 2007; Neale et al., 2010; Yang et al., 2006).”
Consequences of oxidative stress in age-related macular degeneration
Jarrett, S. G., & Boulton, M. E. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.009 · Cited by 537 · see citing works
“…being identified which increase susceptibility to environmental risk factors such as smoking, hypertension, diet, oxidative stress (reviewed in Ding et al. (2009), Khandhadia and Lotery (2010), Montezuma et al. (2007), Swaroop et al. (2009), Ting et al. (2009)) and see review by Gorin in this…”
BackgroundLight-emitting diodes (LED) for domestic lighting: Any risks for the eye?
Béhar‐Cohen, F., Martinsons, C., Viénot, F., Zissis, G., Barlier-Salsi, A., Césarini, J. P., Enouf, O., Garcia, M., Picaud, S. A., & Attia, D. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.04.002 · Cited by 417 · see citing works
“Compared with age-matched controls, patients with advanced age-relatedmacular degeneration (geographic atrophy or disciform scarring) had significantly higher exposure to blue or visible light over the preceding 20 years but were not different in respect to exposure to UV-A or UV-B, suggesting that blue-light exposure…”
BackgroundInfluentialMullins, R. F., Johnson, M. N., Faidley, E. A., Skeie, J. M., & Huang, J. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6476 · Cited by 393 · see citing works
Parainflammation, Chronic Inflammation and Age-Related Macular Degeneration
Chen, M., & Xu, H. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ri0615-239r · Cited by 381 · see citing works
“Whilst we appreciate that multiple pathways may contribute to macular damage, it is now clear that inflammation plays a major role in AMD pathogenesis [10, 26, 27].”
BackgroundIL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis
Fahey, E., & Doyle, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01426 · Cited by 276 · see citing works
A hydrogel-based stem cell delivery system to treat retinal degenerative diseases
Ballios, B. G., Cooke, M. J., van der Kooy, D., & Shoichet, M. S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.12.004 · Cited by 248 · see citing works
Involvement of oxysterols in age-related diseases and ageing processes
Zarrouk, A., Véjux, A., Mackrill, J. J., O’Callaghan, Y. C., Hammami, M., O’Brien, N. M., & Lizard, G. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.09.006 · Cited by 217 · see citing works
Macrophage polarization in the maculae of age‐related macular degeneration: A pilot study
Cao, X., Shen, D., Patel, M. M., Tuo, J., Johnson, T. M., Olsen, T. W., & Chan, C. (2011) · Pathology International · doi:10.1111/j.1440-1827.2011.02695.x · Cited by 211 · see citing works
Self-citationStem cell based therapies for age-related macular degeneration: The promises and the challenges
Nazari, H. K., Zhang, L., Zhu, D., Chader, G. J., Falabella, P., Stefanini, F. R., Rowland, T. J., Clegg, D., Kashani, A. H., Hinton, D. R., et al. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.06.004 · Cited by 207 · see citing works
“…Degeneration Susceptibility 2 (ARMS2)/High Temperature Required Factor A1 (HTRA1) genes, complement component 2/complement factor B (C2/BF, 6p21) genes, and complement component 3 (C3, 19p13) genes are believed to contribute to the pathogenesis of AMD (Ding et al., 2009; Richardson et al., 2009).”
BackgroundInfluentialde Guimarães, T. A. C., Varela, M. D., Georgiou, M., & Michaelides, M. (2021) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-318452 · Cited by 189 · see citing works
Sreekumar, P. G., Ishikawa, K., Spee, C., Mehta, H. H., Wan, J., Yen, K., Cohen, P., Kannan, R., & Hinton, D. R. (2016) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-17053 · Cited by 179 · see citing works
“characterized by RPE cell loss, subsequent degeneration of photoreceptors, and thinning of retina.(4) Oxidative stress and”
BackgroundKohno, H., Chen, Y., Kevany, B. M., Pearlman, E. M., Miyagi, M., Maeda, T., Palczewski, K., & Maeda, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.448712 · Cited by 175 · see citing works
Metabolic physiology in age related macular degeneration
Stefánsson, E., Geirsdóttir, Á., & Sigurðsson, H. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.09.003 · Cited by 171 · see citing works
“…studies have pointed towards an inflammatory component, some clinical trials towards oxidative stress, while physiological studies have suggested that ischemia and hypoxia plays a role (Algvere et al., 2006; Bressler, 2009; Campochiaro, 2004; Curcio et al., 2009; Ding et al., 2009; Feigl, 2009).”
Jones, A. D., Kumar, S., Zhang, N., Tong, Z., Yang, J.-H., Watt, C. B., Anderson, J., Amrita, A., Fillerup, H., McCloskey, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102853108 · Cited by 165 · see citing works
“A age-related macular degeneration (AMD) can be classified into wet AMD and geographic atrophy (1, 2).”
BackgroundRetinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163 · see citing works
“The molecular pathology of dry AMD has demonstrated a role of oxidative stress, inflammation, and metabolic dysregulation (Ding et al. 2009).”
BackgroundInfluentialSelf-citationWeigert, G., Kaya, S., Pemp, B., Sacu, S., Lasta, M., Werkmeister, R. M., Dragostinoff, N., Simader, C., Garhöfer, G., Schmidt-Erfurth, U. M., et al. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7522 · Cited by 160 · see citing works
“On the basis of the risk factor profile, oxidative stress has been implicated in the pathogenesis of the disease related to low-grade inflammation and hypoxia in the outer retina.(5,6) This notion is compatible with the idea that low macular pigment optical density (MPOD) is a risk factor for the disease, because the…”
BackgroundThe role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment
Wang, Y., Wang, V. M., & Chan, C.-C. (2010) · Eye · doi:10.1038/eye.2010.196 · Cited by 160 · see citing works
Self-citationChen, Y., Hu, Y., Zhou, T., Zhou, K. K., Mott, R., Wu, M., Boulton, M. E., Lyons, T. J., Gao, G., & Ma, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080945 · Cited by 159 · see citing works
“Oxidative stress induced by hyperglycemia has been shown to be a key pathogenic factor for retinal inflammation and vascular injury.(46,48) To test the role of the oxidative stress in the Wnt pathway activation induced by high glucose, we used aminoguanidine as it has antioxidant activities.”
MethodComplement, Age-Related Macular Degeneration and a Vision of the Future
Gehrs, K. M. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.18 · Cited by 157 · see citing works
Yuan, X., Gu, X., Crabb, J. S., Yue, X., Shadrach, K. G., Hollyfield, J. G., & Crabb, J. W. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900523-mcp200 · Cited by 154 · see citing works
Healthy Lifestyles Related to Subsequent Prevalence of Age-Related Macular Degeneration
Mares, J. A. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.314 · Cited by 156 · see citing works
“This is because (1) lifestyle was assessed an average of 6 years before photographs documented AMD, (2) most women who had AMD at this point were in early stages (77% of women who had not been previously told that they had AMD), and (3) the women who had AMD were also not likely to have had AMD for many years owing to…”
InfluentialArakawa, S., Takahashi, A., Ashikawa, K., Hosono, N., Aoi, T., Yasuda, M., Oshima, Y., Yoshida, S., Enaida, H., Tsuchihashi, T., et al. (2011) · Nature Genetics · doi:10.1038/ng.938 · Cited by 149 · see citing works
“Although the inflammation of the RPE-choroid interface and the apoptosis of both photoreceptor and RPE cells have crucial roles in the development of AMD, the precise pathogenesis of AMD has not been fully elucidate”
BackgroundLiu, A., Chang, J., Lin, Y., Shen, Z., & Bernstein, P. S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m007518 · Cited by 151 · see citing works
McGuinness, M. B., Le, J., Mitchell, P., Gopinath, B., Cerin, E., Saksens, N. T. M., Schick, T., Hoyng, C. B., Guymer, R. H., & Finger, R. P. (2017) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2017.05.016 · Cited by 144 · see citing works
Tisi, A., Feligioni, M., Passacantando, M., Ciancaglini, M., & Maccarone, R. (2021) · Cells · doi:10.3390/cells10010064 · Cited by 144 · see citing works
“Several experimental data highlight a direct relationship between oxidative stress and choroidal alterations in AMD [93,94].”
BackgroundHagstrom, S. A., Ying, G.-S., Pauer, G. J. T., Sturgill-Short, G. M., Huang, J., Callanan, D. G., Kim, I. K., Klein, M. L., Maguire, M. G., & Martin, D. F. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2012.11.037 · Cited by 142 · see citing works
“It has been hypothesized that overexpression of TRA1 may alter the integrity of Bruch’s membrane and avor the development of CNV.(2) This may suggest that TRA1 would play a role in regulating CNV and therefore ould affect response to anti-VEGF therapy.”
InfluentialAge-related Macular Degeneration: Genetic and Environmental Factors of Disease
Chen, Y., Bedell, M., & Zhang, K. (2010) · Molecular Interventions · doi:10.1124/mi.10.5.4 · Cited by 139 · see citing works
Endoplasmic Reticulum Stress in Age-Related Macular Degeneration: Trigger for Neovascularization
Salminen, A., Kauppinen, A., Hyttinen, J. M. T., Toropainen, E., & Kaarniranta, K. (2010) · Molecular Medicine · doi:10.2119/molmed.2010.00070 · Cited by 138 · see citing works
Mechanism of Inflammation in Age-Related Macular Degeneration
Parmeggiani, F., Romano, M., Costagliola, C., Semeraro, F., Incorvaia, C., D’Angelo, S., Perri, P., Palma, P. D., Nadai, K. D., & Sebastiani, A. (2012) · Mediators of Inflammation · doi:10.1155/2012/546786 · Cited by 135 · see citing works
“In consideration of the heterogeneous gene-gene relationships between the major risk variants of the CFH, ARMS2, and HTRA1 loci, several Authors have emphasized the consistent possibility of an independent multiplicative joint effect in AMD, also taking into account that each of them should be contextualized within ge…”
BackgroundInfluentialImmune Activation in Retinal Aging: A Gene Expression Study
Chen, M., Muckersie, E., Forrester, J. V., & Xu, H. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-5103 · Cited by 130 · see citing works
“It is well known that certain genetic and environmental factors may predispose individuals to glaucoma,(1) diabetic retinopathy,(2) or age-related macular degeneration.(3,4) We hypothesize that agerelated changes in the retina may provide a background that increases susceptibility to the development of these diseases.”
BackgroundBiasutto, L., Chiechi, A., Couch, R., Liotta, L. A., & Espina, V. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.05.005 · Cited by 126 · see citing works
“The aetiology of AMD is multifactorial, including genetic, environmental, nutritional and behavioural factors (Ding et al, 2009; Zarbin, 2004; Kaarniranta and Salminen 2009; Jager et al, 2008); oxidative stress is clearly involved in the pathogenesis (Plafker, 2010; Qin, 2007).”
BackgroundThe role of advanced glycation end products in retinal ageing and disease
Glenn, J. V., & Stitt, A. W. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.016 · Cited by 127 · see citing works
“This indicates that chronic pro-inflammatory factors are likely to occur in unisonwith cumulative protein and lipid modifications in the outer retina and be critical to the degenerative process [31,32].”
BackgroundProtective effect of alpha-mangostin against oxidative stress induced-retinal cell death
Fang, Y., Tu, S., Qiu, X., Mao, P., Xu, Y., Hu, Z., Zhang, Y., Zheng, X., Xie, P., & Liu, Q. (2016) · Scientific Reports · doi:10.1038/srep21018 · Cited by 120 · see citing works
Jiang, D., Xiong, G., Feng, H., Zhang, Z., Chen, P., Yan, B., Chen, L., Kesavamoorthy, G., Ma, C., Li, C., et al. (2019) · Theranostics · doi:10.7150/thno.29422 · Cited by 120 · see citing works
“age related macular degeneration, glaucoma, diabetic retinopathy) [60-62].”
BackgroundAbdominal Obesity and Age-related Macular Degeneration
Adams, M. K. M., Simpson, J. A., Aung, K. Z., Makeyeva, G. A., Giles, G. G., English, D. R., Hopper, J. L., Guymer, R. H., Baird, P. N., & Robman, L. D. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr005 · Cited by 120 · see citing works
Adaptive Optics Technology for High-Resolution Retinal Imaging
Lombardo, M., Serrao, S., Devaney, N. M., Parravano, M., & Lombardo, G. (2012) · Sensors · doi:10.3390/s130100334 · Cited by 120 · see citing works
“Several patho-biological pathways have been implicated in the pathogenesis of AMD: these include senescence, shown by a lipofuscin accumulation in the RPE cells, choroidal ischemia and oxidative damage [148,149].”
BackgroundPhagocyte dysfunction, tissue aging and degeneration
Li, W. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.05.006 · Cited by 114 · see citing works
Varshochian, R., Riazi-Esfahani, M., Jeddi‐Tehrani, M., Mahmoudi, A.-R., Aghazadeh, S., Mahbod, M., Movassat, M., Atyabi, F., Sabzevari, A., & Dinarvand, R. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35446 · Cited by 114 · see citing works
Macrophage polarization in experimental and clinical choroidal neovascularization
Yu, Y., Liu, F., Tang, M., Yuan, M., Hu, A., Zhan, Z., Li, Z., Li, J., Ding, X., & Lü, L. (2016) · Scientific Reports · doi:10.1038/srep30933 · Cited by 114 · see citing works
Self-citationInana, G., Murat, C., An, W., Yao, X., Harris, I. R., & Cao, J. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1434-6 · Cited by 113 · see citing works
Maugeri, A., Barchitta, M., Mazzone, M. G., Giuliano, F., Basile, G., & Agodi, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072118 · Cited by 114 · see citing works
“by the geographic atrophy of RPE and thinning of the retina; the second is characterized by the development of choroidal neovascularization (CNV), which negatively affects central vision [3,4].”
BackgroundBoltz, A., Luksch, A., Wimpissinger, B., Maár, N., Weigert, G., Frantal, S., Brannath, W., Garhöfer, G., Ergun, E., Stur, M., et al. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4968 · Cited by 109 · see citing works
“Most important, advances have been made in unveiling the associated genetic factors.(3,4) Other risk factors that have been identified are mainly of cardiovascular origin.”
Liu, Y., Xu, H., Wang, L., Li, S. Y., Hao, J., Hao, J., Li, Q. Y., Zhao, T. T., Wu, W., Wang, Y., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0053-y · Cited by 110 · see citing works
Immune regulation in the retina
Detrick, B., & Hooks, J. J. (2010) · Immunologic Research · doi:10.1007/s12026-009-8146-1 · Cited by 108 · see citing works
“More recently, immune reactivity has been implicated in retinal diseases, such as AMD, diabetic retinopathy, and retinitis pigmentosa (RP) [1, 2].”
BackgroundYıldırım, Z., Uçgun, N. İ., & Yıldırım, F. (2011) · Clinics · doi:10.1590/s1807-59322011000500006 · Cited by 108 · see citing works
“Although the disease presents a serious social and economic problem, its pathogenesis and etiology are still unclear.(2,3) Based on the disease’s clinical and pathological features, there are two subtypes of late AMD: atrophic (dry) and neovascular (wet), both of which can lead to significant visual loss.”
On the origin of proteins in human drusen: The meet, greet and stick hypothesis
Bergen, A. A., Arya, S., Koster, C., Pilgrim, M. G., Wiatrek-Moumoulidis, D., van der Spek, P. J., Hauck, S. M., Boon, C. J. F., Emri, E., Stewart, A. J., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.12.003 · Cited by 101 · see citing works
Huang, W., Wu, H., Li, D., Song, J., Xiao, Y., Liu, C., Zhou, J., & Sui, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b06135 · Cited by 103 · see citing works
The Pathogenic Role of the Canonical Wnt Pathway in Age-Related Macular Degeneration
Zhou, T., Hu, Y., Chen, Y., Zhou, K., Zhang, B., Gao, G., & Ma, J. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4278 · Cited by 102 · see citing works
“AMD is a multifactorial disease,(1) and the most established risk factors are advanced age, cigarette smoking, diet, and race.(3) Although the pathogenesis of AMD has not been fully elucidated, inflammation has been shown to play a pathogenic role in AMD.”
BackgroundThe Proteomics of DrusenPreprint
Crabb, J. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017194 · Cited by 103 · see citing works
“To date, 19 genetic loci (Fritsche et al. 2013) and multiple environmental factors, including diet and smoking, have been associated with AMD risk (Jager et al. 2008; Ding et al. 2009).”
BackgroundAdaptive Optics Retinal Imaging – Clinical Opportunities and Challenges
Carroll, J., Kay, D. B., Scoles, D., Dubra, A., & Lombardo, M. (2013) · Current Eye Research · doi:10.3109/02713683.2013.784792 · Cited by 100 · see citing works
“choroidal ischemia and oxidative damage.(84,85) There”
Saccà, S. C., Roszkowska, A. M., & Izzotti, A. (2013) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2013.01.001 · Cited by 99 · see citing works
“A growing body of evidence suggests an important role of inflammatory and immunological events in AMD pathogenesis [255,256].”
BackgroundWang, A. L., Lukas, T. J., Yuan, M., Du, N. Y., Handa, J. T., & Neufeld, A. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005304 · Cited by 98 · see citing works
“To better understand the cellular and molecular bases for the association between smoking and AMD, we determined the effects of Benzo(a)Pyrene (B(a)P), a toxic element in cigarette smoke, on cultured retinal pigment epithelia (RPE) and we examined the RPE/choroid from mice exposed to chronic cigarette smoke.”
BackgroundInfluentialInflammatory Mechanisms of Age-related Macular Degeneration
Knickelbein, J. E., Chan, C., Sen, H. N., Ferris, F. L., & Nussenblatt, R. B. (2015) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000073 · Cited by 97 · see citing works
“Mitochondrial damage has been illustrated in human AMD maculae.(53,54) In an in vitro model where mtDNA damage was induced in ARPE-19 cells by treatment with rotenone, a mitochondrial complex I inhibitor, increased autophagy as well as increased exosome release and chemokine secretion were observed.”
BackgroundSelf-citationGanapathy, P. S., White, R. E., Ha, Y., Bozard, B. R., McNeil, P. L., Caldwell, R. W., Kumar, S., Black, S. M., & Smith, S. B. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6870 · Cited by 97 · see citing works
The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases
Kaur, G., & Singh, N. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010386 · Cited by 94 · see citing works
“CX3CR1 facilitates the recruitment of WBCs into the inflamed tissues in the retina and thus the inflammatory cells are subsequently activated [76].”
BackgroundOxygen Sensing in Retinal Health and Disease
Lange, C. A. K., & Bainbridge, J. W. B. (2012) · Ophthalmologica · doi:10.1159/000331418 · Cited by 86 · see citing works
Nashine, S., Cohen, P., Chwa, M., Lu, S. Y., Nesburn, A. B., Kuppermann, B. D., & Kenney, M. C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.348 · Cited by 92 · see citing works
“AMD cybrids showed (1) reduced levels of cell viability, lower mtDNA copy numbers, and downregulation of mitochondrial replication/ transcription genes and antioxidant enzyme genes; and (2) elevated levels of genes related to apoptosis, autophagy and ER-stress along with increased mtDNA fragmentation and higher suscep…”
BackgroundResultInfluentialNanomedicine and drug delivery to the retina: current status and implications for gene therapy
Tawfik, M., Chen, F., Goldberg, J. L., & Sabel, B. A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02287-3 · Cited by 94 · see citing works
Abcouwer, S. F., Lin, C.-M., Wolpert, E. B., Shanmugam, S., Schaefer, É., Freeman, W. M., Barber, A. J., & Antonetti, D. A. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-5264 · Cited by 90 · see citing works
Wang, Y., Zhao, L., Lu, F. L., Yang, X., Deng, Q., Ji, B., & Huang, F. (2015) · Molecules · doi:10.3390/molecules201219785 · Cited by 89 · see citing works
“The pathogenesis of AMD is not well understood, but it is thought that a high oxygen concentration and high levels of polyunsaturated fatty acids in the retina, increasing sensitivity to light exposure and contribute to oxidative stress and inflammation, which injure the RPE, resulting in loss of photoreceptor cells […”
BackgroundNussenblatt, R. B., Byrnes, G., Sen, H. N., Yeh, S., Faia, L. J., MEYERLE, C. B., Wroblewski, K. J., Li, Z., Liu, B., Chew, E. Y., et al. (2010) · Retina · doi:10.1097/iae.0b013e3181e7978e · Cited by 88 · see citing works
“We have hypothesized that any alteration in this downregulatory environment puts one at risk for the development of disorders with the choriocapillaris/retinal pigment epithelium/outer retinal interface.19,29 If this concept can be affirmed, immunosuppressive therapy would then be indicated for both forms of advanced…”
BackgroundInfluentialZhou, Y., Yoshida, S., Nakao, S., Yoshimura, T., Kobayashi, Y., Nakama, T., Kubo, Y., Miyawaki, K., Yamaguchi, M., Ishikawa, K., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16012 · Cited by 87 · see citing works
Evaluation of circulating miRNAs in wet age-related macular degeneration.
Ertekin, S., Yıldırım, Ö., Dinç, E., Ayaz, L., Fidancı, S. B., & Tamer, L. (2014) · PubMed Central · Cited by 87 · see citing works
Issa, P. C., Chong, V. N., & Scholl, H. P. N. (2010) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1568-6 · Cited by 87 · see citing works
Nutritional modulation of age-related macular degeneration
Weikel, K., Chiu, C., & Taylor, A. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.005 · Cited by 88 · see citing works
“Mass spectrometric analysis indicates that drusen contain a variety of lipids, proteins, including ubiquitin and advanced glycation end products, as well as inflammatory mediators (Ding et al., 2009) (also see review by Shang in this issue).”
BackgroundLipécz, Á., Miller, L. R., Kovács, I., Czakó, C. N., Csípő, T., Baffi, J., Csiszár, A., Tarantini, S., Ungvari, Z. I., Yabluchanskiy, A., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00138-3 · Cited by 85 · see citing works
Pons, M., & Marin‐Castaño, M. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016722 · Cited by 85 · see citing works
“While it is largely recognized that macrophages accumulate in AMD lesions [57,58,59,60,61,62,63], there is ambiguity surrounding their role in the disease process with conflicting evidence regarding whether they might be helpful by scavenging accumulated debris and therefore protecting against CNV or harmful by stimul…”
BackgroundKyosseva, S. V., Chen, L., Seal, S., & McGinnis, J. F. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.08.003 · Cited by 82 · see citing works
“AMD is a multifactorial disease that is characterized by degeneration of the retinal photoreceptors, retinal pigment epithelium (RPE), Bruch’s membrane, choriocapillaris, and choroidal tissues (Ding et al., 2009).”
BackgroundCao, X., Liu, M., Tuo, J., Shen, D., & Chan, C. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.03.016 · Cited by 82 · see citing works
“Human RPE cells (ARPE-19) were obtained from the American Type Culture Collection (Manassas, VA, USA) and cultured as described previously (Ding et al., 2009b).”
MethodInfluentialSelf-citationChong, C., & Zheng, W. (2016) · Redox Biology · doi:10.1016/j.redox.2016.06.002 · Cited by 82 · see citing works
“Furthermore, Artemisinin failed to suppress H2O2-induced cytotoxicity and the increase of caspase 3/7 activity in the presence of the ERK inhibitor PD98059.”
BackgroundCurrent therapeutic developments in atrophic age-related macular degeneration
Hanus, J., Zhao, F., & Wang, S. (2015) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2015-306972 · Cited by 81 · see citing works
Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment
Mehrzadi, S., Hemati, K., Reiter, R. J., & Hosseinzadeh, A. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1737015 · Cited by 81 · see citing works
“impaired CFH inhibitory activity results in the accumulation of complement cascade products contributing to the inflammatory damage to RPE cells [82,83].”
BackgroundMorrison, M. A., Silveira, A. C., Huynh, N., Jun, G., Smith, S. E., Zacharaki, F., Satō, H., Loomis, S. J., Andreoli, M. T., Adams, S. M., et al. (2011) · Human Genomics · doi:10.1186/1479-7364-5-6-538 · Cited by 83 · see citing works
Sobrin, L., Reynolds, R., Yu, Y., Fagerness, J., Leveziel, N., Bernstein, P. S., Souied, E. H., Daly, M. J., & Seddon, J. M. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.08.015 · Cited by 78 · see citing works
Genetics of Immunological and Inflammatory Components in Age-related Macular Degeneration
Tuo, J., Grob, S., Zhang, K., & Chan, C. (2012) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2011.628432 · Cited by 80 · see citing works
Self-citationMacular pigment in retinal health and disease
Lima, V. C., Rosen, R. B., & Farah, M. E. (2016) · International Journal of Retina and Vitreous · doi:10.1186/s40942-016-0044-9 · Cited by 80 · see citing works
“It has been shown that oxidative stress related to low-grade inflammation and hypoxia in the outer retina are important in the pathogenesis of AMD [62].”
BackgroundXu, W., Grunwald, J. E., Metelitsina, T. I., DuPont, J. C., Ying, G., Martin, E. R., Dunaief, J. L., & Brucker, A. J. (2010) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2010.01.041 · Cited by 79 · see citing works
Sobrin, L., Ripke, S., Yu, Y., Fagerness, J. A., Bhangale, T., Tan, P. L., Souied, E. H., Buitendijk, G. H. S., Merriam, J. E., Richardson, A. J., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.014 · Cited by 80 · see citing works
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0947-4 · Cited by 80 · see citing works
Du, H., Sun, X., Guma, M., Luo, J., Ouyang, H., Zhang, X., Zeng, J., Quach, J., Nguyen, D. H., Shaw, P. X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221729110 · Cited by 74 · see citing works
“Aging, family history, cigarette smoking, systemic inflammation, and genetic predisposition are risk factors forAMD (5).”
BackgroundInfluentialMechanisms of protein aggregation in the retinal pigment epithelial cells
Kaarniranta, K. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e198 · Cited by 78 · see citing works
“Increased M1 macrophage activity is believed to be a result of disturbed complement system due to gene polymorphisms (102).”
BackgroundLack of Niemann-Pick type C1 induces age-related degeneration in the mouse retina
Claudepierre, T., Paques, M., Simonutti, M., Buard, I., Sahel, J., Maue, R. A., Picaud, S., & Pfrieger, F. W. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.10.007 · Cited by 77 · see citing works
Shah, N., Ishii, M., Brandon, C. S., Ablonczy, Z., Cai, J., Liu, Y., Chou, C. J., & Rohrer, B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.016 · Cited by 77 · see citing works
“These outer segments contain high levels of polyunsaturated fatty acids and photosensitizers, which together increase the production of ROS in the presence of oxygen as well as light [9, 10].”
BackgroundN -methyl- N -nitrosourea-induced retinal degeneration in mice
Chen, Y., Liu, S., Hu, D., Xing, Y., & Shen, Y. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2013.12.019 · Cited by 76 · see citing works
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina
Dasari, B., Prasanthi, J. R. P., Marwarha, G., Singh, B. B., & Ghribi, O. (2011) · BMC Ophthalmology · doi:10.1186/1471-2415-11-22 · Cited by 74 · see citing works
“Extracellular Ab deposition, oxidative stress, and inflammation are implicated in both AD and AMD [4,5].”
BackgroundAbnormal vascularization in mouse retina with dysregulated retinal cholesterol homeostasis
Omarova, S., Charvet, C. D., Reem, R. E., Mast, N., Zheng, W., Huang, S., Peachey, N. S., & Pikuleva, I. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63816 · Cited by 74 · see citing works
“The exact etiology of AMD is currently not fully understood, but is believed to be multifactorial, involving aging and interactions between genetic and environmental factors (6, 7).”
Macrophages in uveal melanoma and in experimental ocular tumor models: Friends or foes?
Jager, M. J., Ly, L. V., el Filali, M., & Madigan, M. C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.11.004 · Cited by 74 · see citing works
Abedi, F., Wickremasinghe, S., Richardson, A. J., Islam, A. F. M., Guymer, R. H., & Baird, P. N. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.014 · Cited by 74 · see citing works
“In addition, HTRA1 inhibits transforming growth factor-b, which regulates angiogenesis.(35) In a recent study of a large cohort of Caucasian patients, Zhang et al(36) suggested that the HTRA1 gene plays a critical role in angiogenesis through transforming growth factor-b family member growth differentiation factor 6 (…”
BackgroundBhattacharya, S., Chaum, E., Johnson, D. A., & Johnson, L. R. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10495 · Cited by 73 · see citing works
Lichtlen, P., Lam, T. T., Nork, T. M., Streit, T., & Urech, D. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4890 · Cited by 74 · see citing works
Ramkumar, H. L., Tuo, J., Shen, D. F., Zhang, J., Cao, X., Chew, E. Y., & Chan, C. (2013) · Journal of Nutrition · doi:10.3945/jn.112.169649 · Cited by 73 · see citing works
“25 (22, 2) in A-DKO mice at 1 mo (U = 152; P = 0.”
BackgroundSelf-citationWankun, X., Yu, W.-Z., Zhao, M., Weiyan, Z., Huan, C., Du, W., Lvzhen, H., Xu, Y., & Li, X. (2011) · Europe PMC (PubMed Central) · Cited by 72 · see citing works
Patel, M. M., Herzlich, A. A., Sauer, T. C., & Chan, C. (2015) · Developments in ophthalmology · doi:10.1159/000431128 · Cited by 70 · see citing works
Self-citationLiu, M. M., Chan, C., & Tuo, J. (2012) · Human Genomics · doi:10.1186/1479-7364-6-13 · Cited by 70 · see citing works
“Common variants Linkage and association studies have implicated genetic modulators of AMD risk related to many mechanistic pathways, including oxidative stress, complement system dysregulation, DNA repair, mitochondrial dysfunction, neovascularization, and microglial recruitment [7].”
BackgroundSelf-citationRat retinal transcriptome: Effects of aging and AMD-like retinopathy
Kozhevnikova, O. S., Korbolina, E. E., Ershov, N., & Kolosova, N. G. (2013) · Cell Cycle · doi:10.4161/cc.24825 · Cited by 71 · see citing works
miRNAs as potential therapeutic targets for age-related macular degeneration
Wang, S., Koster, K. M., He, Y., & Zhou, Q. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.176 · Cited by 67 · see citing works
Oxidative stress induced cellular signaling in RPE cells
Klettner, A. (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/275 · Cited by 67 · see citing works
“The etiology of AMD is complex and includes demographic, genetic and environmental aspects (2).”
Background
- Authors
- Ding, X., Patel, M., & Chan, C.-C.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Chan, Chi-Chao
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 28
- Issue
- 1
- Pages
- 1-18
- ISSN
- 1350-9462 (ISSN-L)
- PMC
- PMC2715284
- OpenAlex
- W2084944408
- Semantic Scholar
- f9eb706832ee615a7771dad2f6ed351095c05219
- Cited by
- 582
- References
- 224
- Citations by year
- 2026: 5 · 2025: 21 · 2024: 17 · 2023: 16 · 2022: 24 · 2021: 43 · 2020: 20 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 33 · 2015: 39 · 2014: 39 · 2013: 44 · 2012: 53
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Progress in Retinal and Eye Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (Z01EY000222, Z01EY000418)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- age-related macular degeneration, molecular pathology, genetic susceptibility, complement factor H, CX3CR1, inflammation, apoptosis, cholesterol transport, angiogenesis, oxidative stress, retinal pigment epithelium, Bruch's membrane, choroidal capillaries, photoreceptor degeneration, animal models
- MeSH terms
- Animals, Disease Models, Animal, Humans, Macular Degeneration, Retina, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review